Document:

Exhibit
10.8

 

THIS
NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER UNITED STATES FEDERAL OR STATE SECURITIES
LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, OR OTHERWISE TRANSFERRED OR ASSIGNED FOR VALUE, DIRECTLY OR INDIRECTLY, NOR MAY THIS
NOTE OR THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE BE TRANSFERRED ON THE BOOKS OF THE COMPANY, WITHOUT REGISTRATION
OF SUCH NOTE OR SECURITIES, AS APPLICABLE, UNDER ALL APPLICABLE UNITED STATES FEDERAL OR STATE SECURITIES LAWS OR COMPLIANCE WITH
AN APPLICABLE EXEMPTION THEREFROM, SUCH COMPLIANCE, AT THE OPTION OF THE COMPANY, TO BE EVIDENCED BY AN OPINION OF STOCKHOLDER’S
COUNSEL, IN A FORM ACCEPTABLE TO THE COMPANY, THAT NO VIOLATION OF SUCH REGISTRATION PROVISIONS WOULD RESULT FROM ANY PROPOSED
TRANSFER OR ASSIGNMENT.

 

HOME
TREASURE FINDERS, INC.

 

CONVERTIBLE PROMISSORY NOTE

 

	$207,122.69	 	Denver
    Colorado	 	October
    15, 2019

 

FOR
VALUE RECEIVED, the Holder, HOME TREASURE FINDERS, INC., a Colorado corporation, and its successors and assigns (the “Company”),
promises to pay to the order of ENERGY HUNTER RESOURCES, INC. or its successors and permitted assigns
(“Holder”), the principal sum of TWO HUNDRED SEVEN THOUSAND ONE HUNDRED AND TWENTY-TWO Dollars and
SIXTY-NINE cents ($207,122.69), together with interest from October 15, 2019 on the balance of this Note from time to time
remaining unpaid at a rate of 4.00% per annum until maturity, both principal and interest being payable at the address
designated in Section 13, or at such other place as Holder may from time to time designate in writing.

 

The
principal of this Note shall mature and be due and payable on November 1, 2021.

 

All
accrued and unpaid interest shall be due and payable immediately on maturity of the principal of this Note.

 

All
past due principal and accrued interest on this Note shall bear interest from maturity until paid at the rate of 10.00% per annum.

 

     

     

    

 

All
payments under this Note shall be payable in lawful money of the United States of America which shall be legal tender for public
and private debts at the time of payments.

 

As
used in this Note, “senior indebtedness” means all indebtedness or other monetary obligations of the Company
that are secured by assets of the Company (if any) or for which the instrument creating or evidencing the same or pursuant to
which the same is outstanding expressly provides that such indebtedness or obligation shall be senior in right of payment to this
Note or the Company’s subordinated indebtedness.

 

Section
1. CONVERSION. Commencing 180 days subsequent to the date of this Note, any portion or all of the principal and accrued
interest payable pursuant to the terms of this Note shall be convertible by the Holder at any time prior to payment into the no
par value common stock of the Company (the "Common Stock") at the rate of $0.352 of principal and/or interest
per share; provided, however, if the Company files a registration statement, which permits the registration of issued and outstanding
shares for resale in accordance with the provisions of Section 2 of this Note, the Holder shall have the right to convert on and
after the effective date of such registration statement if the date occurs prior to 180 days prior to the date of this Note. The
Company agrees at all times to reserve from its authorized but unissued shares a sufficient number of shares of Common Stock to
satisfy the Holder's rights of conversion as set forth herein.

 

Section
2. REGISTRATION. The Holder understands and acknowledges that the offering of the Securities pursuant to this Note
will not be registered under the Securities Act of 1933 or qualified under the Colorado Law on the grounds that the offering and
sale of the securities contemplated by this Note are exempt from registration under the Securities Act and exempt from qualification
pursuant to Colorado Law, and that Company's reliance upon such exemptions is predicated upon Investor's representations set forth
in this Note and/or Subscription Agreement. The Company shall have no obligation to register the common shares issued pursuant
to the conversion rights set forth herein unless the Company files a form of registration statement pursuant to the Securities
Act which permits the registration of issued and outstanding shares for resale under which circumstances it shall include all
of the shares issued pursuant to the Holder’s rights of conversion.

 

    2

     

    

 

Section
3. PREPAYMENTS. Commencing 90 days subsequent to the date of this note, the principal and/or interest on this Note
may be prepaid in whole or in part without penalty and without the prior consent of Holder provided that no payments of principal
or interest shall be made without providing at least 30 days prior notice to the Holder in writing to permit the Holder to exercise
his rights of conversion provided for in Section 1.

 

Section
4. DEFAULT; REMEDIES.

 

(a) The
Company shall be in default under this Note upon the happening of any condition or event set forth below (each, an “Event
of Default”):

 

(i) The
Company’s failure to pay any payment of principal or interest as and when due in accordance with the terms of this Note;

 

(ii) default
by the Company in the punctual performance of any other obligation, covenant, term or provision contained in this Note or the
default by the Company in any senior indebtedness, and such default shall continue unremedied for a period of 10 days or more
following written notice of default by Holder to the Company;

 

(iii) if
that certain Stock Purchase Agreement, dated as of August 15, 2019, between the Company, HMTF Merger Sub, Inc., the Holder, and
certain stockholders of the Holder (as set forth therein) is terminated for any reason prior to the consummation of the transactions
contemplated in such agreement;

 

(iv) if
the Company fails to make payment to any payee set forth on Appendix A hereto in the amount set opposite such payee’s name,
other than any payment to a payee which Holder has agreed to pay directly as specifically noted on Appendix A, within five (5)
business days after Company’s receipt of the principal amount (less the funds which are paid directly by Holder to payees);
or

 

(v) the
Company’s dissolution, termination of existence, insolvency or business failure; the appointment of a receiver of all or
any part of the property of the Company; an assignment for the benefit of creditors by the Company; or the commencement of any
proceeding under any bankruptcy or insolvency laws by or against the Company or any guarantor, surety or endorser for the Company
which results in the entry of an order for relief or which remains undismissed, undischarged or unbonded for a period of 60 days
or more.

 

    3

     

    

 

(b) The
entire unpaid principal balance of this Note and all accrued interest on such unpaid principal balance shall immediately be due
and payable at the option of the Holder upon the occurrence of any one or more of the Events of Default and at any time after
the occurrence of any one or more of the Events of Default.

 

Section
5. CUMULATIVE RIGHTS. No delay on the part of the Holder in the exercise of any power or right under this Note or
under any other instrument executed pursuant to this Agreement shall operate as a waiver of any such power or right, nor shall
a single or partial exercise of any power or right preclude other or further exercise of such power or right or the exercise of
any other power or right.

 

Section
6. WAIVER. The Company and all endorsers, sureties and guarantors of this Note waive demand, presentment, protest,
notice of dishonor, notice of nonpayment, notice of intention to accelerate or notice of acceleration other than notice of default
pursuant to Section 3(a)(ii), notice of protest and any and all lack of diligence or delay in collection or the filing
of suit on this Note which may occur, and agree to all extensions and partial payments, before or after maturity, without prejudice
to the holder of this Note.

 

Section
7. ATTORNEYS’ FEES AND COSTS. In the event that this Note is collected in whole or in part through suit, arbitration,
mediation, or other legal proceeding of any nature, then and in any such case there shall be added to the unpaid principal amount
of this Note all reasonable costs and expenses of collection, including, without limitation, reasonable attorney’s fees.

 

Section
8. GOVERNING LAW. This Note shall be governed by and construed in accordance with the internal laws of the State
of Colorado, without giving effect to conflicts of law provision or rule (whether of the State of Colorado or any other jurisdiction)
that would result in the application of the laws of any jurisdiction other than the State of Colorado.

 

Section
9. HEADINGS. The headings and captions used in this Note are used for convenience only and are not to be
considered in construing or interpreting this Note. All references in this Note to sections, paragraphs, exhibits, and
schedules shall, unless otherwise provided, refer to sections and paragraphs of this Note and exhibits and schedules attached
to this Note, all of which exhibits and schedules are incorporated in this Note by this reference.

 

    4

     

    

 

Section
10. USURY. All agreements between the Company and the holders of this Note, whether now existing or hereafter
arising and whether written or oral, are expressly limited so that in no contingency or event whatsoever, whether by
acceleration of the maturity of this Note or otherwise, shall the amount paid, or agreed to be paid, to the holder of this
Note for the use, forbearance or detention of the money to be loaned under this Agreement or otherwise, exceed the maximum
amount permissible under applicable Colorado law. If from any circumstances whatsoever fulfillment of any provision of this
Note or of any other document evidencing, securing or pertaining to the indebtedness evidenced by this Note, at the time
performance of such provision shall be due, shall involve transcending the limit of validity prescribed by law, then ipso
facto, the obligation to be fulfilled shall be reduced to the limit of such validity, and if from any such circumstances the
holder of this Note shall ever receive anything of value as interest or deemed interest by applicable law under this Note or
any other document evidencing, securing or pertaining to the indebtedness evidenced by this Note or otherwise an amount that
would exceed the highest lawful rate, such amount that would be excessive interest shall be applied to the reduction of the
principal amount owing under this Note or on account of any other indebtedness of the Company to the holder of this Note
relating to this Note, and not to the payment of interest, or if such excessive interest exceeds the unpaid balance of
principal of this Note and such other indebtedness, such excess shall be refunded to the Company. In determining whether or
not the interest paid or payable with respect to any indebtedness of the Company to the holder of this Note, under any
specific contingency, exceeds the highest lawful rate, the Company and the holder of this Note shall, to the maximum extent
permitted by applicable law, (a) characterize any non-principal payment as an expense, fee or premium rather than as
interest, (b) amortize, prorate, allocate and spread the total amount of interest throughout the full term of such
indebtedness so that the actual rate of interest on account of such indebtedness is uniform throughout the term of such
indebtedness, and/or (c) allocate interest between portions of such indebtedness, to the end that no such portion shall bear
interest at a rate greater than that permitted by law. The terms and provisions of this Section shall control and supersede
every other conflicting provision of all agreements between the Company and the holders of this Note. The Holders has been
advised by the Company to seek the advice of an attorney and an accountant in connection with the issuance of this Note. The
Company has had the opportunity to seek the advice of an attorney and accountant of the Company’s choice in connection
with issuance of this Note.

 

    5

     

    

 

Section
11. SUCCESSORS AND ASSIGNS. This Note may not be sold, transferred or otherwise assigned by Holder without the prior
written consent of the Company. All of the stipulations, promises and agreements in this Note made by or on behalf of the Company
shall bind the successors and assigns of the Company, whether so expressed or not, and inure to the benefit of the successors
and permitted assigns of the Holder.

 

Section
12. SEVERABILITY. If one or more provisions of this Note are held to be unenforceable under applicable law, such
provision(s) shall be excluded from this Note and the balance of this Note shall be interpreted as if such provision(s) were so
excluded and shall be enforceable in accordance with its terms.

 

Section
13. NOTICES. All notices, requests, consents, and other communications under this Note shall be in writing and shall
be delivered personally or by facsimile transmission or by nationally recognized overnight delivery service or by first class
certified or registered mail, return receipt requested, postage prepaid:

 

If
to the Company, at 4045 Pecos St., Suite 110, Denver, CO 80211 Attention: Corey Wiegand, or at such other address or addresses
as may have been furnished by giving five days advance written notice to all other parties, with a copy (which shall not constitute
notice) to Roger V Davidson, Esquire, 2540 Westward Dr., Lafayette, CO 80026.

 

If
to the Holder at, P.O. Box 540308, Dallas, TX 75354, Attention Gary C. Evans or at such other address or addresses as may have
been furnished by giving five days advance written notice to all other parties, with a copy (which shall not constitute notice)
to. Duane Morris LLP, 1540 Broadway, New York, New York 10036, Attention: Dean Colucci.

 

Notices
provided in accordance with this Section shall be deemed delivered upon personal delivery (including confirmed facsimile) or three
business days after deposit in the mail.

 

    6

     

    

 

IN
WITNESS WHEREOF, the Company and the Holder have executed this Note on and as of the date first above written.

 

	 	Home Treasure Finders, Inc.
	 	 	 
	 	By:  	/s/ Corey Wiegand
	 	 	Corey Wiegand
	 	 	President

 

     

     

    

 

NOTICE
OF CONVERSION

 

Dated
this __day of ___________________, 20__;

 

This
is to acknowledge that on the date and year first above set forth the Holder has made an irrevocable election to convert
$_____________ of the principal amount and $_____________ of accrued interest under the Note into the Common Shares of
the Company pursuant to the conversion rights as established in the Note. Please immediately issue the appropriate
certificate for the Common Shares and deliver it to the Holder at:

 

_____________________________________. The conversion is at
the rate established in the Note, $0.352 of principal and interest converted for each whole share of the Common Shares.

 

______________________

 

Holder

 

     

     

    

 

APPENDIX
A

 

CONVERTIBLE
    NOTE PRINCIPAL

ACCOUNTS
    PAYABLE COVERED BY ENERGY HUNTER

 

	Payee	 	Amount	 
	Garfield Note Payment*	 	$	150,000.00	 
	Haynie & Company*	 	$	24,610.00	 
	State of Colorado (Property Taxes)	 	$	11,587.68	 
	Warehouse Roof*	 	$	10,000.00	 
	Roger Davidson	 	$	4,400.00	 
	Costar (MLS)	 	$	2,494.00	 
	Edgar Tech (SEC filings)	 	$	1,580.00	 
	Standard Registrar (Transfer Agent)	 	$	1,284.00	 
	Mary Daling (Bookkeeper)	 	$	684.00	 
	City of Denver (Fire Inspection Lien)	 	$	483.01	 
	 	 	 	 	 
	TOTAL	 	$	207,122.69	 

 

		*	Payee
                                         to be paid directly by Energy HunterExhibit 10.9

 

SECURITIES EXCHANGE AGREEMENT

 

THIS SECURITIES EXCHANGE
AGREEMENT (this “Agreement”) dated as of November 27, 2019 among:

 

(a) ENERGY
HUNTER RESOURCES, INC., a Delaware corporation (the “Company”),

 

(b) Certain
former- convertible preferred shareholders of the Company, each of whom are listed on Schedule A hereto (each, a “Transferor”,
and collectively, the “Transferors”); and

 

(c) GENERATION
HEMP, INC., a Colorado corporation (“GENH”).

 

Background

 

1 On
August 15, 2019, GENH, formerly known as Home Treasure Finders, Inc., entered into a Stock Purchase Agreement (as amended, the
“Stock Purchase Agreement”) among GENH, HMTF Merger Sub Inc., a Colorado corporation (as “Buyer”
and together with GENH, the “Buyer Parties”), the Company, certain stockholders of the Company set for therein
(as “Sellers”), and Gary C. Evans (as the “Sellers’ Representative”) pursuant to which, the
Company, GENH and Buyer intended to effect a merger of Buyer with and into the Company (the “Merger”) in accordance
with this Agreement and the General Corporation Law of the State of Delaware (the “DGCL”), whereupon consummation
of the Merger, Buyer ceased to exist and the Company became a Subsidiary of GENH.

 

2. In
furtherance of the Merger, Buyer Parties purchased from Sellers 6,328,948 shares of its common stock, par value $0.0001 per share
representing approximately 91% of the issued and outstanding common stock of the Company as of August 15, 2019. Upon closing, the
Sellers received from GENH 6,328,948 shares of Series A Convertible Preferred Stock and the Company became a direct subsidiary
of GENH.

 

3. Prior
to the closing of the transactions contemplated under the Stock Purchase Agreement, the Transferors held 100% the shares of Series
C Preferred Stock of the Company (“Series C”) as set forth on Schedule A which converted as of the closing
date of the that certain Stock Purchase Agreement, (collectively, the “Converted Company Shares”).

 

4. At
the time of the closing of the transactions contemplated under the Stock Purchase Agreement and as more fully disclosed in the
Form 8-K filed on December 20, 2019 (the “December 20 8-K”) upon such closing by GENH at the Securities and
Exchange Commission (the “SEC”) GENH, the Company, and Sellers Representative agreed to GENH’s desire
to acquire all of the Converted Company Shares from the Transferors.

 

     

     

    

 

5. In
fulfillment of the requirement of Section 1.2(b) of the Stock Purchase Agreement, as amended and as set forth in the December 20
8-K, the Transferors have agreed to exchange their Converted Company Shares for shares of Common Stock of GENH (“Common
Stock”) for the Exchange Securities (as defined below).

 

NOW, THEREFORE,
in consideration of the mutual promises, covenants and agreements herein, and intending to be legally bound hereby, the parties
agree as follows:

 

1. Equity
Exchange.

 

a. Exchange.

 

i. On
the terms and subject to the conditions set forth in this Agreement, at the closing of the Exchange (the “Closing”)
(x) the Transferors will assign, transfer, exchange and convey to GENH, free and clear of all liens, pledges, encumbrances, security
interests, mortgages, hypothecations, charges, restrictions or known claims of any kind, nature or description (“Liens”),
and GENH will accept from the Transferors, the Converted Company Shares in the amounts as set forth on Schedule A, and (y)
in exchange for the transfer of such securities by the Transferors, GENH will assign, transfer, exchange and convey to the Transferors
, and the Transferors will accept from GENH, the Exchange Securities in the individual amounts as set forth on Schedule B
(such exchange, the “Exchange”). For the avoidance of doubt, each Transferor will receive (a) one share of Common
Stock (the “Exchange Shares”), (b) one cashless exercise warrants to purchase three shares of Common Stock in
accordance with the terms and provisions as set forth in the form of warrant attached hereto as Exhibit A (the “Cashless
Warrant”), and (c) one cash exercise warrants to purchase three shares of Common Stock in accordance with the terms and
provisions as set forth in the form of warrant attached hereto as Exhibit B (the “Cash Warrant” and together
with the Cashless Warrant, the “Warrants”)(the Warrants, together with the Exchange Shares, the “Exchange
Securities”).

 

b. The
Closing. The Closing shall occur concurrently with the execution and delivery of this Agreement by the parties at
the offices of Duane Morris LLP, 1540 Broadway, New York, New York 10036 at 11:00 a.m. (Eastern Time) or in
any case at such other location, date and time or by such other means (e.g., e-mail/PDF or facsimile and overnight
delivery of original execution documents) as may be agreed by the parties in writing. The
date upon which the Closing shall actually occur pursuant hereto is referred to herein as the “Closing Date.”

 

2. Representations
and Warranties.

 

a. Representations
and Warranties of the Transferors. Each Transferor severally, and not jointly, hereby represents and warrants to the Company
and GENH, all of which representations and warranties are true, complete, and correct
in all respects as of the date hereof, and will be as of the Closing Date, as follows:

 

i. Authorization;
No Restrictions, Consents or Approvals. Such Transferor has the full right, power (and capacity, if the Transferor is an individual)
and authority to enter into and perform such Transferor’s obligations under this Agreement; and no approvals or consents
are necessary in connection with it. Such Transferor (if the Transferor is not an individual) is duly incorporated, organized or
formed, validly existing and in good standing under the laws of its state or country of incorporation, organization or formation
(as the case may be). This Agreement, when executed and delivered by such Transferor, will constitute a valid and legally binding
obligation of the Transferor, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and similar laws affecting creditors’ rights generally and subject, as to enforceability,
to general principles of equity. The person signing this Agreement to bind such Transferor has been duly authorized by such Transferor
to do so.

 

    2

     

    

 

ii. Transfer
of Converted Company Shares. All of the Converted Company Shares owned by such Transferor are owned free and clear of all Liens.
The Converted Company Shares owned by such Transferor will be validly transferred to GENH free and clear of all Liens and taxes
with respect to the transfer thereof. By countersigning below, the undersigned does hereby waive any transfer restrictions, rights
of first refusal or any other rights that such party may have under the organizational documents of the Company or otherwise in
respect of the transfer of any Transferor’s Converted Company Shares pursuant to this Agreement.

 

iii. Investment
Representations.

 

1. Each
such Transferor understands that the Exchange Securities have not been, and may never be, registered under the Securities Act of
1933, as amended (the “Securities Act”) or any other applicable securities laws, including those under the Colorado
corporations Code or the Delaware Securities Act. Each such Transferor also understands that the Exchange Securities are being
issued pursuant to an exemption from the registration requirements of the Securities Act, under Section 4(2) and/or Regulation
D of the Securities Act, he Colorado corporate code, and of the Delaware Securities Act. Each such Transferor acknowledges that
GENH will rely on such Transferor’s representations, warranties and certifications set forth below for purposes of determining
such Transferor’s suitability as an investor in the Exchange Securities and for purposes of confirming the availability of
the Section 4(2) and/or Regulation D exemption from the registration requirements of the Securities Act, of the Section 25012(f)
exemption under the Colorado corporate code and of the applicable exemption under the Delaware Securities Act. Such Transferor
understands that the Exchange Securities will be “restricted securities” under applicable U.S. federal and state securities
laws and that, pursuant to these laws, such Transferor must hold the Exchange Securities indefinitely unless they are registered
with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification
requirements is available. Such Transferor acknowledges that GENH has no obligation to register or qualify the Exchange Securities,
or any equity interests or other securities into which they may be converted, for resale. Such Transferor further acknowledges
that if an exemption from registration or qualification is available, it may be conditioned on various requirements including,
but not limited to, the time and manner of sale, the holding period for the Exchange Securities, and on requirements relating to
GENH which are outside of such Transferor’s control, and which GENH may be under no obligation, and may not be able to, satisfy.
Such Transferor understands that GENH is under no obligation to assist such Transferor in complying with any exemption from registration
under the securities or similar laws of any jurisdiction whatsoever.

 

2. Each
such Transferor has received all the information such Transferor considers necessary or appropriate for deciding whether to acquire
and accept the Exchange Securities, including information describing GENH and the risk factors associated with GENH’s business
as set forth on Exhibit C hereto, which such exhibit is expressly incorporated herein by reference. Each such Transferor
understands the risks involved in an investment in the Exchange Securities. Each such Transferor further represents that such Transferor
has had an opportunity to ask questions and receive answers from GENH regarding the terms and conditions of the Exchange, and the
business, properties, prospects, and financial condition of GENH and the Company and to obtain such additional information (to
the extent that GENH and/or the Company possessed such information or could acquire it without unreasonable effort or expense)
necessary to verify the accuracy of any information furnished to such Transferor or to which such Transferor had access. Each such
Transferor further represents that such Transferor is an “accredited investor” within the meaning of Rule 501(a) of
the Securities Act and that such Transferor is capable of bearing the high degree of economic risk and burdens of its investment
in the Exchange Securities, including, but not limited to, the possibility of the complete loss of all funds invested, the loss
of any anticipated tax benefits, the lack of a public market for the Exchange Securities, the unavailability of redemption for
the Exchange Securities, which may make the liquidation of this investment impossible for the indefinite future. Such Transferor
further understands and acknowledges that no federal or state agency has made any finding or determination as to the fairness of
the Exchange Securities for investment or any recommendation or endorsement of the Exchange Securities.

 

    3

     

    

 

3. Each
such Transferor is accepting the Exchange Securities for such Transferor’s own account for investment only, not as a nominee
or agent, and not with a view to the resale or “distribution” (within the meaning of the Securities Act) of any part
thereof, and that such Transferor has no present intention of selling, granting any participation in, or otherwise distributing
the same. By executing this Agreement, such Transferor further represents that the Transferor does not presently have any contract
or agreement with any person or entity to sell, transfer or grant participations to such person, entity or to any third person,
with respect to the Exchange Securities. If other than an individual, such Transferor represents that it has not been formed solely
for the purpose of acquiring the Exchange Securities.

 

4. Each
such Transferor understands that the Exchange Securities may not be offered, sold or otherwise transferred except in compliance
with the registration requirements of the Securities Act and any other applicable securities laws or pursuant to an exemption therefrom,
and in each case in compliance with the conditions set forth in this Agreement.

 

5. Each
such Transferor acknowledges and agrees that each certificate representing the Exchange Securities shall bear a legend substantially
similar to the following:

 

THE SECURITIES REPRESENTED
HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES
LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION, UNLESS THE TRANSFEROR
DELIVERS TO THE COMPANY AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT THE PROPOSED SALE, TRANSFER OR OTHER
DISPOSITION MAY BE EFFECTED WITHOUT REGISTRATION UNDER THE ACT AND UNDER APPLICABLE STATE SECURITIES OR “BLUE SKY”
LAWS.”

 

6. Each
such Transferor has a pre-existing personal or business relationship with GENH, its subsidiaries, and/or its principal executive
officers, or, by reason of such Transferor’s business or financial experience (or the business or financial experience of
the Transferor’s professional advisors who are not affiliated with and who are not compensated by GENH or any Affiliate of
GENH) has the capacity to protect his, her or its own interests in connection with an investment in the Exchange Securities, and
either alone or with the Transferor’s professional advisors (as described above) has such knowledge and experience in financial
and business matters that the Transferor is capable of evaluating the merits and risks of an investment in GENH.

 

7. Such
Transferor understands and acknowledges that any discussions about GENH’s business, management, financial affairs and the
terms and conditions of the offerings of the Exchange Securities with the management and/or other representatives of GENH, as well
as any written information issued by GENH, including without limitation, the business plan of GENH: (i) were intended to describe
the aspects of GENH’s business and prospects that GENH believes to be material, but were not necessarily an exhaustive description,
and (ii) may have contained forward-looking statements involving known and unknown risks and uncertainties that may cause GENH’s
actual results in future periods or plans for future periods to differ materially from what was anticipated and that no representations
or warranties were or are being made with respect to any such forward-looking statements or the probability of achieving any of
the results projected in any of such forward-looking statements.

 

    4

     

    

 

8. Neither
the directors, officers, managers, employees nor any agent of GENH, nor any broker dealer or other person has at any time expressly
or implicitly represented, guaranteed or warranted to such Transferor: (i) the approximate or exact length of time that such Transferor
will be required to hold the Exchange Securities; (ii) that such Transferor may freely transfer the Exchange Securities; (iii)
the percentage of profit and/or amount of or type of consideration, profit, benefit or loss to be realized, if any, as a result
of an investment in the Exchange Securities; (iv) that past performance of GENH and/or past performance or experience on the part
of the directors, officers, managers or employees of GENH or any other person in any way indicates or predicts the economic or
other results of the ownership of the Exchange Securities or of the overall GENH business; (v) that any cash or stock distributions
from GENH’s operations or otherwise will be made to GENH’s stockholders by any specific date or will be made at all;
or (vi) that any specific tax benefits will accrue as a result of an investment in GENH.

 

9. Such
Transferor is a sophisticated investor and acknowledges that he, she or it is able to fend for himself, herself or itself, can
bear the full economic risk of his, her or its investment in the Exchange Securities and has such knowledge and experience in financial
or business matters that it is capable of evaluating the merits and risks of the investment in the Exchange Securities, and has
in fact evaluated such risks and determined that the Exchange Securities is a suitable investment for such Transferor. Such Transferor
is an experienced investor with respect to non-listed, unregistered and restricted securities and speculative and high-risk ventures,
and specifically, such Transferor has such investment experience and expertise in cannabis and/or cannabis-related industries.

 

10. Neither
such Transferor nor any other person who, within the meaning of Section 506(d) of Regulation D under the Securities Act, would
be a “beneficial owner of 20% or more of the issuer’s outstanding voting equity securities” with respect to such
Transferor’s interest in GENH, is subject to any Disqualifying Event or is subject to any proceeding or event that could
result in any such Disqualifying Event. “Disqualifying Event” means any of the events listed in subsections (i) through
(vii) of Section 506(d) of Regulation D.

 

11. If
such Transferor is not a United States person (as defined by Section 7701(a)(30) of the Code), such Transferor hereby represents
that he, she or it has satisfied himself, herself or itself as to the full observance of the laws of its jurisdiction in connection
with any invitation to purchase or accept the Exchange Securities or any use of this Agreement, including: (i) the legal requirements
within its jurisdiction for the purchase or acceptance of the Exchange Securities; (ii) any foreign exchange restrictions
applicable to such purchase or acceptance; (iii) any governmental or other consents that may need to be obtained; and (iv) the
income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of
the Exchange Securities. Such Transferor’s purchase or acceptance of the Exchange Securities will not violate any applicable
securities or other laws of such Transferor’s jurisdiction.

 

12. Neither
such Transferor, nor any of its directors, officers, managers, employees, agents, stockholders, members or partners has in connection
with the offer and sale of the Exchange Securities either directly or indirectly, including, through a broker or finder: (i) engaged
in any general solicitation; or (ii) published any advertisement. The offer to sell or convey the Exchange Securities was
directly communicated to such Transferor on behalf of GENH by an authorized representative of GENH. At no time was such Transferor
presented with or solicited by or through any article, notice or other communication published in any newspaper or other leaflet,
public promotional meeting, television, radio or other broadcast or transmittal advertisement or any other form of general advertising.

 

13. Such
Transferor is not purchasing the Exchange Securities with funds that constitute, directly or indirectly, the assets of an employee
benefit plan subject to Title I of the Employee Retirement Income Security Act of 1974, as amended, or Section 4975 of the Code,
nor is such Transferor a “benefit plan investor” within the meaning of 29 C.F.R. Section 2510.3-101(f) issued by the
United States Department of Labor.

 

14. The
residence or principal place of business, as applicable, of such Transferor is set forth on the signature page to this Agreement.

 

    5

     

    

 

iv. Accuracy
of Information and Indemnification by Transferor. All of the representations and warranties of such Transferor contained in
this Agreement and all information provided by such Transferor to GENH in this Agreement are true, accurate, complete and correct
in all respects on the date hereof.

 

b. Representations
and Warranties of the Company. The Company and its Subsidiaries hereby jointly and severally represent and warrant to the Transferors
and GENH, all of which representations and warranties are true, complete, and correct in all respects as of the date hereof and
will be as of the Closing Date, as follows:

 

i. Organization
and Qualification. The Company is a corporation validly existing and in good standing under the laws of Delaware and has all
requisite power and authority to own and operate its properties and assets and to carry on its business as presently conducted
and is qualified to do business and is in good standing in each jurisdiction where the ownership or operation of its assets or
properties or conduct of its business requires such qualification.

 

ii. Authorization;
No Restrictions, Consents or Approvals. The Company has full power and authority to enter into and perform its obligations
under this Agreement. This Agreement has been duly executed by the Company and constitutes the legal, valid, binding and enforceable
obligation of the Company, enforceable against the Company in accordance with its terms, subject to applicable bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and similar laws affecting creditors’ rights generally and subject, as
to enforceability, to general principles of equity. The execution and delivery of this Agreement and the consummation by the Company
of the transactions contemplated herein do not and will not on the Closing Date (A) conflict with or violate any of the terms of
the articles of incorporation and other organizational documents of the Company, (B) conflict with, or result in a breach of any
of the terms of, or result in the acceleration of any indebtedness or obligations under, any material agreement, obligation or
instrument by which the Company is bound or to which any property of the Company is subject, or constitute a default thereunder,
other than those material agreements, obligations or instruments for which the Company has obtained consent for the transactions
contemplated under this Agreement, (C) result in the creation or imposition of any Lien on any of the assets of the Company, (D)
constitute an event permitting termination of any material agreement or instrument to which the Company is a party or by which
any property or asset of the Company is bound or affected, pursuant to the terms of such agreement or instrument, other than those
material agreements or instruments for which the Company has obtained consent for the transactions contemplated under this Agreement,
or (E) conflict with, or result in or constitute a default under or breach or violation of or grounds for termination of, any license,
permit or other governmental authorization to which the Company is a party or by which the Company may be bound, or result in the
violation by the Company of any laws to which the Company may be subject, which would materially adversely affect the transactions
contemplated herein.

 

iii. Consents.
The execution, delivery and performance by each of the Company and its Subsidiaries of this Agreement and each ancillary agreement
to which it is a party does not and will not require any consent, approval, authorization or other order of, action by, filing
with or notification to, any Governmental Authority or any other Person.

 

    6

     

    

 

c. Representations
and Warranties of GENH. Except as set forth in (i) Annual Report on Form 10-K for the fiscal year ended December 31, 2018,
Quarterly Report on Form 10-Q for the period ended September 30, 2019, (the “Covered Parent SEC Disclosure”),
GENH hereby represents and warrants to the Transferors, all of which representations and warranties are true, complete, and correct
in all respects as of the date hereof and will be as of the Closing Date, as follows:

 

i. Organization
and Qualification. GENH is a corporation validly existing and in good standing under the laws of the State of Colorado and
has all requisite power and authority to own and operate its properties and assets and to carry on its business as presently conducted
and is qualified to do business and is in good standing in each jurisdiction where the ownership or operation of its assets or
properties or conduct of its business requires such qualification.

 

ii. Authorization;
No Restrictions, Consents or Approvals. GENH has full power and authority to enter into and perform its obligations under this
Agreement. This Agreement has been duly executed by GENH and constitutes the legal, valid, binding and enforceable obligation of
GENH, enforceable against GENH in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance,
reorganization, moratorium and similar laws affecting creditors’ rights generally and subject, as to enforceability, to general
principles of equity. The execution and delivery of this Agreement and the consummation by GENH of the transactions contemplated
herein (including the issuance of the Exchange Securities in exchange for the Converted Company Shares) do not and will not on
the Closing Date (A) conflict with or violate any of the terms of the certificate of incorporation and bylaws of GENH, (B) conflict
with, or result in a breach of any of the terms of, or result in the acceleration of any indebtedness or obligations under, any
material agreement, obligation or instrument by which GENH is bound or to which any property of GENH is subject, or constitute
a default thereunder, other than those material agreements, obligations or instruments for which GENH has obtained consent for
the transactions contemplated under this Agreement, (C) result in the creation or imposition of any Lien on any of the assets of
GENH, (D) constitute an event permitting termination of any material agreement or instrument to which GENH is a party or by which
any property or asset of GENH is bound or affected, pursuant to the terms of such agreement or instrument, other than those material
agreements or instruments for which GENH has obtained consent for the transactions contemplated under this Agreement, or (E) conflict
with, or result in or constitute a default under or breach or violation of or grounds for termination of, any license, permit or
other governmental authorization to which GENH is a party or by which GENH may be bound, or result in the violation by GENH of
any laws to which GENH may be subject, which would materially adversely affect the transactions contemplated herein. No authorization,
consent or approval of, notice to, or filing with, any public body or Governmental Authority or any other person is necessary or
required in connection with the execution and delivery by GENH of this Agreement or the performance by GENH of its obligations
hereunder.

 

iii. Issuance
of Shares. The Exchange Securities have been duly authorized and, upon issuance in accordance with the terms hereof, shall
be validly issued and free from all taxes, Liens and charges with respect to the issue thereof, and the Exchange Securities shall
be fully paid and non-assessable with the holder being entitled to all rights accorded to a holder of GENH common stock.

 

iv. Consents.
The execution, delivery and performance by GENH of this Agreement and each ancillary agreement to which it is a party does not
and will not require any consent, approval, authorization or other order of, action by, filing with or notification to, any Governmental
Authority or any other Person.

 

    7

     

    

 

v. Financial
Statements. GENH has made available to the Trasnferors (by public filing with the SEC via EDGAR or otherwise) a true and complete
copy of each report, schedule, registration statement, other statement (including proxy statements) and information filed by GENH
with the SEC since January 1, 2016 (the “GENH SEC Documents”). GENH has made 12b-25 filings with the SEC in
connection with being unable to file the Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and the Quarterly
Report on Form 10-Q for the period ended March 31, 2020 on a timely basis. Such 12b-25 filings disclose the late filings of GENH
over the last 12 months. As of the date hereof, such 10-K and 10-Q have not yet been filed and the Trasnferors are aware of GENH’s
late filings. As of their respective dates, the GENH SEC Documents which have been filed have complied in all material respects
with the requirements of the Securities Act, the Sarbanes-Oxley Act of 2002 and the Exchange Act, as applicable, and the rules
and regulations of the SEC thereunder applicable to such GENH SEC Documents, in each case, as in effect at such time, and none
of the GENH SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be
stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading,
except to the extent such statements have been modified or superseded by later GENH SEC Documents filed and publicly available
prior to the date of this Agreement. No Subsidiary of GENH is required (by contract or applicable Law) to make periodic filings
with the SEC. The consolidated financial statements of GENH (including the notes thereto) included or incorporated by reference
in the GENH SEC Documents (including the audited consolidated balance sheet of GENH as at December 31, 2018 (the “GENH
Balance Sheet”) and the unaudited consolidated statements of income for the nine months ended September 30, 2019) complied
as to form in all material respects with the applicable accounting requirements and the published rules and regulations of the
SEC with respect thereto, were prepared in accordance with GAAP applied on a consistent basis during the periods involved (except
as may be indicated in the notes thereto, or, in the case of the unaudited statements, as permitted by Rule 10-01 of Regulation
S-X of the SEC) and fairly present, in accordance with applicable requirements of GAAP and the applicable rules and regulations
of the SEC (subject, in the case of the unaudited statements, to normal, recurring adjustments, none of which are material), in
each case, as in effect at such time, the assets, Liabilities and the consolidated financial position of GENH and its Subsidiaries,
taken as a whole, as of their respective dates and the consolidated results of operations and cash flows of GENH and its Subsidiaries
taken as a whole, for the periods presented therein.

 

vi. Brokers.
No broker, finder, investment banker or financial advisor is entitled to any brokerage, finder’s or other fee or commission
in connection with the transactions contemplated by this Agreement or any Ancillary Agreement based upon arrangements made by or
on behalf of GENH or any Subsidiary.

 

vii. No Other
Representations and Warranties. Except for the representations and warranties set forth in this Section 2., as modified
by the Buyer Parties Disclosure Schedules, the other Ancillary Documents and any certificate delivered pursuant hereto or thereto,
neither GENH, Buyer, nor any of their respective Representatives has made nor make any representation or warranty, express or
implied, written or oral, with respect to the transactions contemplated by this Agreement and the other Ancillary Documents, and
each of Buyer and GENH hereby disclaims any other representations and warranties, whether made orally or in writing, by or on
behalf of Buyer or GENH by any Person. The Buyer Parties acknowledge and agree that each has conducted to its satisfaction its
own independent investigation of the condition, operations and Liabilities of the Company and, in making its determination to
proceed with the transactions contemplated by this Agreement and the other Ancillary Documents, the Buyer Parties have relied
solely on the results of their own independent investigation and the express representations and warranties set forth in Section 2., as modified by the Company Disclosure Schedules, the Ancillary Documents and any certificate
delivered pursuant hereto or thereto.

 

    8

     

    

 

3. 
“Market Stand-Off” Agreement.

 

a. Agreement
to Lock-Up. Each Transferor hereby agrees that, in connection with a a Public Offering, initial or otherwise, of GENH (an “Public
Offering”), unless not required by the managing underwriter or lead placement agent of the Public Offering, it will enter
into a lock-up agreement in customary form and subject to customary exceptions pursuant to which such Transferor will agree that
it will not, during the period commencing on the date of the final prospectus or offering circular relating to an Public Offering
and ending on the date specified by the managing underwriter or lead placement agent, not to exceed 180 days from the date of the
final prospectus or offering circular relating to the Public Offering (unless reasonably requested by the managing underwriter
or lead placement agent in order to accommodate regulatory restrictions on (1) the publication or other distribution of research
reports, and (2) analyst recommendations and opinions, pursuant to any applicable the restrictions contained in FINRA Rule 2711(f)(4)
or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto) (the “Lock-Up Period”): (a) lend,
offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant
any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of GENH held
immediately prior to the effectiveness of the registration statement or offering statement for the Public Offering; or (b) enter
into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of the Exchange Securities, whether any such transaction described in clause (a) or (b) above is to be settled by delivery of the
Exchange Securities or other securities, in cash or otherwise; provided that each other holder of Equity Interests of GENH
is bound by a substantially similar lock-up agreement. The foregoing provisions of this Section 3 shall not apply to the
sale of any shares to an underwriter pursuant to an underwriting agreement. The underwriters, placement agents and selling agents,
if any, in connection with the Public Offering are intended third-party beneficiaries of this Section 3 and shall have the
right, power and authority to enforce the provisions hereof as though they were a party hereto. Each Transferor agrees to execute
such agreements as may be reasonably requested by the underwriters, placement agents or selling agents in the Public Offering that
are consistent with this Section 3 or that are necessary to give further effect thereto, provided, however,
that the obligation of each Transferor hereunder shall be conditioned on each officer, director and 5% beneficial holder of the
Exchange Securities entering into an agreement in substantially the same form in connection with the Public Offering.

 

b. Stop
Transfer Instructions. In order to enforce the foregoing covenant, GENH may impose stop transfer instructions with respect
to the Exchange Securities of each Transferor (and transferees and assignees thereof) until the end of the Lock-Up Period.

 

4. [RESERVED].

 

5. Closing
Deliverables. At the Closing:

 

a. Each
Transferor shall deliver to GENH:

 

i. any
and all certificates evidencing the Converted Company Shares, together with stock powers duly executed for such certificates to
allow such certificates to be registered in the name of GENH; and

 

ii. such
other certificates, documents, schedules, agreements, resolutions, consents, approvals, rulings or other instruments as may be
reasonably requested by GENH in order to effectuate or evidence the transactions contemplated hereby.

 

b. GENH
shall deliver to each Transferor a statement from the company’s transfer agent evidencing the Exchange Securities registered
in the name of such Transferor in accordance with Schedule B;

 

    9

     

    

 

6. Indemnification.
Each Transferor, severally, and not jointly, will indemnify and hold harmless GENH and its respective directors, officers, managers,
members, employees, and representatives (collectively, the “GENH Indemnitees”) who is a party or is threatened
to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, brought by reason
of or arising from any breach or untruth of any of the representations and warranties of such Transferor set forth in this Agreement,
against losses, liabilities and expenses for which the GENH Indemnitees have not otherwise been reimbursed (including reasonable
attorneys’ fees, judgments, fines and amounts paid in settlement) actually and reasonably incurred by the GENH Indemnitees
in connection with that action, suit or proceeding. GENH, will indemnify and hold harmless each Transferor and its respective directors,
officers, managers, members, employees, and representatives (collectively, the “Transferor Indemnitees”), who
is a party or is threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative,
brought by reason of or arising from any breach or untruth of any of the representations and warranties of GENH set forth in this
Agreement, against losses, liabilities and expenses for which the Transferor Indemnitees have not otherwise been reimbursed (including
reasonable attorneys’ fees, judgments, fines and amounts paid in settlement) actually and reasonably incurred by the Transferor
Indemnitees in connection with that action, suit or proceeding. Notwithstanding the foregoing, (a) the aggregate maximum liability
of each Transferor hereunder shall be an amount equal to the value of the equity interests held by such Transferor prior to the
Closing as set forth on Schedule A; and (b) the aggregate maximum liability of GENH hereunder shall be an amount equal to
the value of the equity interests held by the Transferors collectively prior to the Closing as set forth on Schedule A.
From and after the Closing, indemnification under this Section 7 will be the sole and exclusive remedy of the GENH Indemnitees
and Transferor Indemnitees, as applicable, for breach of any representation or warranty contained in this Agreement, and the parties
shall have no other liability to any other party resulting from any such breach.

 

7. General
Provisions.

 

a. Releases
and Waivers of the Transferors. Each Transferor on its own behalf hereby acknowledges and agrees that the number of the Converted
Company Shares set forth on Schedule A opposite such Transferor’s name represents the total number and type of the
Converted Company Shares held by such Transferor as of the date of this Agreement and as of the Closing Date. Each Transferor hereby
releases the Company and GENH from all obligations, liabilities and causes of action arising before, on or after the date of this
Agreement, out of or in relation to any entitlement which such Transferor may have with respect to any the Converted Company Shares
or any other interest in the Company in excess of the number of the Converted Company Shares set forth opposite such Transferor’s
name on Schedule A. Each Transferor hereby generally, irrevocably, unconditionally and completely waives any and all rights
to receive any anti-dilution protection or other participation rights to which such Transferor may be entitled under the articles
of organization, certificate of formation or other organizational documents of the Company or under any other agreement or instrument
in connection with the Exchange. Except for the Exchange Securities to be issued in connection with the Exchange, each Transferor
hereby generally, irrevocably, unconditionally and completely waives any and all rights existing as of the date hereof to receive
options, warrants, or similar rights to acquire or receive securities in the Company or GENH.

 

b. [RESERVED]

 

c. Governing
Law. This Agreement shall be construed according to the laws of the State of Delaware in effect as of the date hereof, without
giving effect to any principle or doctrine regarding conflicts of law.

 

    10

     

    

 

d. Arbitration
and Dispute Resolution. The parties intend that this Section 7(d) will be valid, binding, enforceable, exclusive and
irrevocable and that it shall survive any termination of this Agreement.

 

i. Upon
any dispute, controversy or claim arising out of or relating to this Agreement or the enforcement, breach, termination or validity
thereof (“Dispute”), the party raising the Dispute will give written notice to the other parties to the Dispute
describing the nature of the Dispute following which the parties to such Dispute shall attempt for a period of ten (10) business
days from receipt by the parties of notice of such Dispute to resolve such Dispute by negotiation between representatives of the
parties hereto who have authority to settle such Dispute. All such negotiations shall be confidential and any statements or offers
made therein shall be treated as compromise and settlement negotiations for purposes of any applicable rules of evidence and shall
not be admissible as evidence in any subsequent proceeding for any purpose. The statute of limitations applicable to the commencement
of a lawsuit shall apply to the commencement of an arbitration hereunder, except that no defense based on the running of the statute
of limitations will be available based upon the passage of time during any such negotiation. Regardless of the foregoing, a party
shall have the right to seek immediate injunctive relief pursuant to Section 8(e)(iii) below without regard to any such
ten (10) business day negotiation period.

 

ii. Any
Dispute (including the determination of the scope or applicability of this agreement to arbitrate) that is not resolved pursuant
to Section 8(e)(i) above shall be submitted to final and binding arbitration in Texas before one neutral and impartial arbitrator,
in accordance with the Laws of the State of Texas for agreements made in and to be performed in that State. The arbitration shall
be administered by JAMS (“JAMS”) pursuant to its Comprehensive Arbitration Rules and Procedures, as in effect
on the date hereof. GENH, on the one hand, and any Transferors, on the other hand, shall appoint a single arbitrator (who shall
be a retired judge or justice) within fifteen (15) days of a demand for arbitration. If GENH and the relevant Transferors cannot
mutually agree upon an arbitrator within such 15-day period, the arbitrator shall be appointed by JAMS in accordance with its Expedited
Arbitration Rules and Procedures, as in effect on the date hereof. The arbitrator shall designate the place and time of the hearing.
The hearing shall be scheduled to begin as soon as practicable and no later than thirty (30) days after the appointment of the
arbitrator (unless such period is extended by the arbitrator for good cause shown) and shall be conducted as expeditiously as possible.
The award, which shall set forth the arbitrator’s findings of fact and conclusions of law, shall be filed with JAMS and mailed
to the parties no later than thirty (30) days after the close of the arbitration hearing. The arbitration award shall be final
and binding on the parties and not subject to collateral attack. Judgment upon the arbitration award may be entered in any federal
or state court having jurisdiction thereof.

 

iii. Notwithstanding
the parties’ agreement to submit all Disputes to final and binding arbitration before JAMS, the parties shall have the right
to seek and obtain temporary or preliminary injunctive relief in any court having jurisdiction thereof. Such courts shall have
authority to, among other things, grant temporary or provisional injunctive relief in order to protect any party’s rights
under this Agreement. Without prejudice to such provisional remedies as may be available under the jurisdiction of a court, the
arbitral tribunal shall have full authority to grant provisional remedies and to direct the parties to request that any court modify
or vacate any temporary or preliminary relief issued by such court, and to award damages for the failure of any party to respect
the arbitral tribunal’s orders to that effect.

 

iv. The
prevailing party shall be entitled to recover its costs and reasonable attorneys’ fees, and the non-prevailing party shall
pay all expenses and fees of JAMS, all costs of the stenographic record, all expenses of witnesses or proofs that may have been
produced at the direction of the arbitrator, and the fees, costs, and expenses of the arbitrator. The arbitrator shall allocate
such costs and designate the prevailing party or parties for these purposes.

 

e. Severability.
If any provision of this Agreement is held by a court or other tribunal of competent jurisdiction to be invalid or unenforceable
for any reason, the remaining provisions shall continue in full force and effect without being impaired or invalidated in any way,
and the parties agree to replace any invalid provision with a valid provision which most closely approximates the intent and economic
effect of the invalid provision.

 

    11

     

    

 

f. Waiver.
The waiver by a party of a breach of or default under any provision of this Agreement shall not be effective unless in writing
and shall not be construed as a waiver of any subsequent breach of or default under the same or any other provision of this Agreement.
Further, any failure or delay on the part of any party to exercise or avail itself of any right or remedy that it has or may have
hereunder shall not operate as a waiver of any such right or remedy or preclude other or further exercise thereof or of any other
right or remedy.

 

g. Notices.
All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed
to have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent
by a nationally recognized overnight courier (receipt requested); (c) on the date sent by e-mail of a PDF document (with confirmation
of transmission) if sent during normal business hours of the recipient, and on the next Business Day if sent after normal business
hours of the recipient; or (d) on the third day after the date mailed, by certified or registered mail, return receipt requested,
postage prepaid. Such communications must be sent to the respective parties at the following addresses (or at such other address
for a Party as shall be specified in a notice given in accordance with this Section 8(h):

 

	 	If to Transferors:	Names and Contact Information as set forth on Schedule A
	 	 	 
	 	If to Company:	Energy Hunter Resources, Inc..
	 	 	5128 Horseshoe Trail
	 	 	Dallas, Texas 75209
	 	 	Attention: Gary C. Evans
	 	 	Email: gevans@energyhunter.energy
	 	 	 
	 	If to GENH:	Generation Hemp, Inc.
	 	 	P.O. Box 540308
	 	 	Dallas, Texas 75354
	 	 	Attention: Gary C. Evans
	 	 	Email: gevans@genhempinc.com
	 	 	 
	 	with a copy (which copy shall not constitute notice) to:
	 	 	 
	 	 	Duane Morris LLP
	 	 	1540 Broadway
	 	 	New York, NY 10036
	 	 	Attention: Dean M. Colucci
	 	 	Email: dmcolucci@duanemorris.com

 

h. No
Third Party Beneficiaries. Nothing in this Agreement shall be construed to confer any rights or benefits upon any person other
than the parties hereto, and no other person shall have any rights or remedies hereunder.

 

i. Termination.
This Agreement may be terminated upon written notice at any time prior to Closing by the written consent of the parties. Termination
of this Agreement will terminate all rights and obligations of the parties under this Agreement and this Agreement will become
void and have no force or effect.

 

j. Entire
Agreement. This Agreement constitutes the entire agreement between the parties and supersedes all prior oral and written agreements
between the parties hereto with respect to the subject matter hereof.

 

    12

     

    

 

k. Advice
of Counsel. The parties represent and warrant to each other that, prior to the execution of this Agreement, they sought the
advice of independent legal counsel of their own selection regarding the substance of this Agreement, or have had the opportunity
to consult with independent legal counsel and have knowingly chosen not to do so.

 

l. Counterparts.
This Agreement may be executed in one or more counterparts (including fax or .pdf counterparts) each of which shall be deemed an
original and all of which shall be taken together and deemed to be one instrument.

 

m. Definitions.
The following terms, as used herein, have the following meanings:

 

“Action”
means any claim, charge, action, suit, arbitration, mediation, inquiry, hearing, audit, proceeding or investigation by or before
any Governmental Authority, including any audit, claim or assessment for Taxes or otherwise.

 

“Affiliate”
means, with respect to any specified Person, any other Person that directly or indirectly through one or more intermediaries, controls,
is controlled by, or is under common control with, such specified Person. A Person shall be deemed to control another Person if
such Person possesses, directly or indirectly, the power to direct, or cause the direction of, the management and policies of such
other Person, whether through the ownership of voting securities, by contract or otherwise.

 

“Code”
means the Internal Revenue Code of 1986, as amended.

 

“Contract”
means any written or oral contract, agreement, indenture, commitment, note, bond, loan, instrument, lease, conditional sale contract,
mortgage, license, arrangement or other legally binding agreement or obligation.

 

“Equity Interests”
shall mean (i) any capital stock of a corporation, any partnership interest, any limited liability company interest or any
other equity interest; (ii) any security or right convertible into, exchangeable for, or evidencing the right to subscribe
for, any such stock, equity interest or security referred to in clause (i); (iii) any stock appreciation right, contingent
value right or similar security or right that is derivative of any such stock, equity interest or security referred to in clause
(i) or (ii); and (iv) any contract to grant, issue, award, convey or sell any of the foregoing.

 

“GAAP”
means United States generally accepted accounting principles in effect from time to time applied consistently throughout the periods
involved.

 

“Governmental
Authority” means any federal, national, foreign, state, provincial, local, or similar government, governmental, regulatory
or administrative authority, agency, bureau, department, board, panel or commission or any court, tribunal, or judicial or arbitral
body or mediator or any other instrumentality of any kind of any of the foregoing.

 

“Governmental
Order” means any order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any
Governmental Authority.

 

“Liabilities”
means with respect to any Person, any and all debts, liabilities or obligations of such Person of any kind or nature whatsoever,
whether asserted or unasserted, known or unknown, accrued or unaccrued, absolute or contingent, matured or unmatured, liquidated
or unliquidated, secured or unsecured, joint or several, due or to become due, vested or unvested, executory, determined, determinable
or otherwise, and whether or not the same is required to be accrued on the financial statements of such Person, including those
arising under any Law, Action or Governmental Order and those arising under any Contract or undertaking.

 

    13

     

    

 

“Lien”
means any charge, claim, condition, lien, option, pledge, security interest, mortgage deed of trust, right of way, easement, encroachment,
servitude, right of first option, right of first or last negotiation or refusal or similar restriction, including any restriction
on use, voting (in the case of any security or equity interest), transfer, receipt of income or exercise of any other attribute
of ownership.

 

“Organizational
Documents” means, with respect to any Person that is not an individual, (a) such Person’s certificate of incorporation
and bylaws, (b) such Person’s certificate of formation, certificate of trust, limited liability company agreement, limited
partnership agreement or trust agreement, or (c) any documents comparable to those described in clauses (a) and (b) as may be applicable
pursuant to any applicable Law, and (d) any amendment or modification to any of the foregoing.

 

“Person”
means an individual, corporation, partnership (including a general partnership, limited partnership or limited liability partnership),
limited liability company, association, trust or other entity or organization, whether for-profit, not-for-profit or otherwise,
and including a government, domestic or foreign, or political subdivision thereof, or an agency or instrumentality thereof.

 

“Subsidiary”
shall mean, with respect to any Person, any entity, whether incorporated or unincorporated, of which (i) voting power to elect
a majority of the board of directors or others performing similar functions with respect to such other Person is held by the first
mentioned Person and/or by any one or more of its Subsidiaries or (ii) at least 50% of the Equity Interests of such other
Person is, directly or indirectly, owned or controlled by such first mentioned Person and/or by any one or more of its Subsidiaries

 

“Tax(es)”
means any federal, state, local or non-U.S. tax, charge, fee, levy, custom, duty, deficiency, or other assessment of any kind or
nature whatsoever imposed by any Taxing Authority (including, without limitation, any income (net or gross), gross receipts, profits,
windfall profit, premium, customs duty, capital stock, sales, use, goods and services, ad valorem, franchise, license, stamp, withholding,
employment, social security (or similar), workers compensation, unemployment compensation, disability, employment, payroll, severance,
occupation, transfer, excise, import, real property, personal property, intangible property, occupancy, registration, recording,
value added, minimum, unclaimed property, escheat payments, alternative minimum, environmental or estimated tax), including any
liability therefor as a transferee (including under Section 6901 of the Code or similar provision of applicable Law) or successor,
as a result of Treasury Regulation Section 1.1502-6 or similar provision of applicable Law or as a result of any Tax sharing, indemnification
or similar agreement, together with any

 

“Taxing Authority”
means the Internal Revenue Service and any other Governmental Authority responsible for the collection, assessment or imposition
of any Tax or the administration of any Law relating to any Tax.

 

[Signature Pages Follow]

 

    14

     

    

 

IN WITNESS WHEREOF,
the undersigned hereby agree to be bound by the terms and provisions of this Securities Exchange Agreement as of the date first
above written.

 

	 	GENH:
	 	GENERATION HEMP, INC.,
	 	a Colorado corporation
	 	 	 
	 	By:	 /s/ Gary C. Evans
	 	Name: 	 Gary C. Evans
	 	Title:	 Chairman and CEO
	 	 	 
	 	 	 
	 	COMPANY:
	 	ENERGY HUNTER RESOURCES, INC.,
	 	a Delaware corporation
	 	 	 
	 	By:	 /s/ Gary C. Evans
	 	Name:	 Gary C. Evans
	 	Title:	 Chairman and CEO

 

     

     

    

 

	 	TRANSFERORS:
	 	 
	 	Coventry Asset Management
	 	 	 
	 	By:	/s/ Gen Fukunaga
	 	Name: 	 
	 	Title:	
	 	 	 
	 	By:	/s/ Gary Elliston
	 	Name: 	 
	 	Title: 	 
	 	 	 
	 	By:	/s/ Jodi Harris
	 	Name: 	 
	 	Title: 	 
	 	 	 
	 	By:	/s/ Joe L. McClaugherty
	 	Name: 	 
	 	Title: 	 
	 	 	 
	 	By:	/s/ Don McLean
	 	Name: 	 
	 	Title: 	 
	 	 	 
	 	By:	/s/ Michael McManus
	 	Name: 	 
	 	Title: 	 
	 	 	 
	 	By:	/s/ Julie Silcock
	 	Name: 	 
	 	Title:	 

 

     

     

    

 

SCHEDULE A

 

TRANSFERORS

 

	Investor	 	Dollar Amount of Original Investment For EHR Preferred Shares	 	 	Number of GENH Shares (Common) Post conversion	 	 	Cash Refund For Fractional Shares	 
	 	 	 	 	 	 	 	 	 	 
	Coventry Asset Management, Ltd. (Gen Fukunaga)	 	$	300,000.00	 	 	 	852,272	 	 	$	0.27	 
	Julie Silcock	 	$	100,000.00	 	 	 	284,090	 	 	$	0.32	 
	Jodi Harris	 	$	25,000.00	 	 	 	71,022	 	 	$	0.26	 
	Gary Elliston	 	$	250,000.00	 	 	 	710,227	 	 	$	0.11	 
	Don McLean	 	$	100,000.00	 	 	 	284,090	 	 	$	0.32	 
	Joe McClaugherty	 	$	25,000.00	 	 	 	71,022	 	 	$	0.26	 
	Michael McManus	 	$	50,000.00	 	 	 	142,045	 	 	$	0.16	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Total	 	$	850,000.00	 	 	 	2,414,768	 	 	 	 	 

 

     

     

    

 

SCHEDULE B

 

GENH SHARES

 

	Investor	 	Number of GENH Shares (Common) Post conversion	 
	 	 	 	 
	Coventry Asset Management, Ltd. (Gen Fukunaga)	 	 	852,272	 
	Julie Silcock	 	 	284,090	 
	Jodi Harris	 	 	71,022	 
	Gary Elliston	 	 	710,227	 
	Don McLean	 	 	284,090	 
	Joe McClaugherty	 	 	71,022	 
	Michael McManus	 	 	142,045	 
	 	 	 	 	 
	Total	 	 	2,414,768	 

 

Schedule
B

 

     

     

    

 

EXHIBIT A

 

FORM OF CASHLESS WARRANT

 

NEITHER THIS SECURITY NOR THE SECURITIES
FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH
EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.

 

GENERATION HEMP, INC.

 

WARRANT TO PURCHASE COMMON STOCK

(with Cashless Exercise)

 

Warrant No.: ___

Number of Shares of Common Stock: 3

Date of Issuance: November 27, 2019 (“Issuance Date”)

 

Generation
Hemp, Inc., a Colorado corporation (the “Company”), hereby certifies that, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, [ ● ],
the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set
forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon surrender of this Warrant
to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the
“Warrant”), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time, on
the Expiration Date (as defined below), 3  (three) fully paid non-assessable shares of Common Stock (as defined below) (the
“Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings
set forth in Section 16. This Warrant is the Warrant to purchase Common Stock (this “Warrant”) issued pursuant
to Section 1(a) of that certain Securities Exchange Agreement (the “Securities Exchange Agreement”), dated as
of this date (the “Exchange Date”), by and between the Company and the Transferors (as defined therein).

 

1.  EXERCISE OF
WARRANT.

 

(a) Mechanics
of Exercise. Subject to the terms and conditions hereof, this Warrant may be exercised by the Holder on any day on or after
the thirtieth (30th) day after the Issuance Date, in whole or in part, by (i) delivery of a written notice, in the form
attached hereto as Exhibit A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant
and (ii) (A) payment to the Company of an amount equal to the applicable Exercise Price multiplied by the number of Warrant Shares
as to which this Warrant is being exercised (the “Aggregate Exercise Price”) in cash or by wire transfer of
immediately available funds or (B) provided the conditions for cashless exercise set forth in Section 1(d) are satisfied, by notifying
the Company that this Warrant is being exercised pursuant to a Cashless Exercise (as defined in Section 1(d)). The Holder shall
not be required to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise
Notice with respect to less than all of the Warrant Shares shall have the same effect as cancellation of the original Warrant and
issuance of a new Warrant evidencing the right to purchase the remaining number of Warrant Shares. On or before the first (1st
) Business Day following the date on which the Company has received each of the Exercise Notice and the Aggregate Exercise Price
(or notice of a Cashless Exercise) (collectively, the “Exercise Delivery Documents”), the Company shall transmit
by facsimile or electronic mail an acknowledgment of receipt of the Exercise Delivery Documents to the Holder and Continental Stock
Transfer & Trust Company (the Company’s “Transfer Agent”). On or before the third (3rd) Business Day
following the date on which the Company has received all of the Exercise Delivery Documents (the “Share Delivery Date”),
the Company shall cause the Shares to be issued in the name of and delivered to the Holder (i) written confirmation that the Shares
have been issued in the name of the Holder, and (ii) a new warrant of like tenor to purchase all of the Shares that may be purchased
pursuant to the portion, if any, of this Warrant not exercised by the Holder. No fractional shares of Common Stock are to be issued
upon the exercise of this Warrant, but rather the number of shares of Common Stock to be issued shall be rounded down to the nearest
whole number.

 

     

     

    

 

(b) Exercise
Price. For purposes of this Warrant, “Exercise Price” means $0.352 subject to adjustment as provided
herein.

 

(c) Cashless
Exercise.Notwithstanding anything contained herein to the contrary, the Holder may exercise this Warrant in whole
or in part and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment
of the Aggregate Exercise Price, elect instead to receive upon such exercise the “Net Number” of shares of Common Stock
determined according to the following formula (a “Cashless Exercise”):

 

	Net Number =	(A x B) - (A x C)	 
	 	B	 
	 	 	 
	For purposes of the foregoing formula:

 

	A=	the total number of shares with respect to which this Warrant is then being exercised.

 

	B=	the arithmetic average of the Closing Sale Prices of the shares of Common Stock for the five (5) consecutive Trading Days ending on the Trading Day immediately preceding the date of the Exercise Notice.

 

	C=	the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

 

For sake of clarity, regardless of whether
an effective registration statement or an exemption from registration is or is not available, there is no circumstance that requires
the Company to effect a net cash settlement of the Warrants.

 

(d) Rule 144.
For purposes of Rule 144(d) promulgated under the Securities Act, as in effect on the date hereof, it is intended that the
Warrant Shares issued in a Cashless Exercise shall be deemed to have been acquired by the Holder, and the holding period for the
Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued pursuant to the Securities Exchange
Agreement.

 

     

     

    

 

(e) Disputes.
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares,
the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed, and all such disputes shall
be resolved pursuant to Section 13.

 

(f)  Legend.
The Holder acknowledges that each certificate evidencing the Warrant Shares acquired upon the exercise of this Warrant will
have restrictions upon resale imposed by state and federal securities laws. Each such certificate shall be stamped or imprinted
with a legend substantially in the following form:

 

THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES
LAWS OF ANY STATE AND MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER APPLICABLE FEDERAL
AND STATE SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO SUCH EFFECT, WHICH OPINION SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.

 

(g) Beneficial
Ownership. The Company shall not effect the exercise of this Warrant, and the Holder shall not have the right to exercise this
Warrant, to the extent that after giving effect to such exercise, such Person (together with such Person’s affiliates) would
beneficially own in excess of 9.99% (the “Maximum Percentage”) of the shares of Common Stock outstanding immediately
after giving effect to such exercise (including in connection with any Fundamental Transaction (as defined below)). For purposes
of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such Person and its affiliates
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination
of such sentence is being made, but shall exclude shares of Common Stock which would be issuable upon (i) exercise of the remaining,
unexercised portion of this Warrant beneficially owned by such Person and its affiliates and (ii) exercise or conversion of the
unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person and its affiliates
(including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion
or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph,
beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended. For
purposes of this Warrant, in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of
outstanding shares of Common Stock as reflected in (1) the Company’s most recent Form 10-K, Form 10-Q, Current Report on
Form 8-K or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement
by the Company or (3) any other notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock
outstanding. To the extent that the limitation contained in this Section 1(f) applies, the determination of whether this Warrant
is exercisable (in relation to other securities owned by such Holder) and of which a portion of this Warrant is exercisable shall
be in the sole discretion of a Holder, and the submission of an Exercise Notice shall be deemed to be each Holder’s determination
of whether this Warrant is exercisable (in relation to other securities owned by such Holder) and of which portion of this Warrant
is exercisable, in each case subject to such aggregate percentage limitation, and the Company shall have no obligation to verify
or confirm the accuracy of such determination. For any reason at any time, upon the written or oral request of the Holder, the
Company shall within two (2) Business Days confirm to the Holder the number of shares of Common Stock then outstanding. In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder and its affiliates since the date as of which such number of outstanding
shares of Common Stock was reported. By written notice to the Company, the Holder may from time to time increase or decrease the
Maximum Percentage to any other percentage not in excess of 9.99% specified in such notice; provided that (i) any such increase
will not be effective until the sixty-first (61st) day after such notice is delivered to the Company, and (ii) any such increase
or decrease will apply only to the Holder. The provisions of this paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 1(g) to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended beneficial ownership limitation herein contained or to make changes or supplements necessary
or desirable to properly give effect to such limitation.

 

     

     

    

 

2.  ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price and the number of Warrant Shares shall be adjusted from
time to time as follows:

 

(a) Adjustment upon
Subdivision or Combination of Common Stock. If the Company at any time on or after the Exchange Date subdivides (by any
stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or otherwise) one or more classes of its outstanding
shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to such subdivision will
be proportionately reduced and the number of Warrant Shares will be proportionately increased. If the Company at any time on or
after the Exchange Date combines (by any stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or
otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in
effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately
decreased. Any adjustment under this Section 2(a) shall become effective at the close of business on the date the subdivision or
combination becomes effective.

 

(b) Other Events.
If any event occurs of the type contemplated by the provisions of this Section 2 but not expressly provided for by such provisions
(including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features),
then the Company’s Board of Directors will make an appropriate adjustment in the Exercise Price and the number of Warrant
Shares so as to protect the rights of the Holder; provided that no such adjustment pursuant to this Section 2(b) will increase
the Exercise Price or decrease the number of Warrant Shares as otherwise determined pursuant to this Section 2 .

 

3. RIGHTS UPON DISTRIBUTION OF ASSETS.
If the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to
all holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution
of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this
Warrant, then, in each such case:

 

(a) any Exercise Price
in effect immediately prior to the close of business on the record date fixed for the determination of holders of shares of Common
Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such record date, to a price
determined by multiplying such Exercise Price by a fraction of which (i) the numerator shall be the Closing Bid Price of the shares
of Common Stock on the Trading Day immediately preceding such record date minus the value of the Distribution (as determined in
good faith by the Company’s Board of Directors) applicable to one share of Common Stock, and (ii) the denominator shall be
the Closing Bid Price of the shares of Common Stock on the Trading Day immediately preceding such record date; and

 

     

     

    

 

(b) the number of Warrant
Shares shall be increased to a number of shares equal to the number of shares of Common Stock obtainable immediately prior to the
close of business on the record date fixed for the determination of holders of shares of Common Stock entitled to receive the Distribution
multiplied by the reciprocal of the fraction set forth in the immediately preceding paragraph (a); provided that in the
event that the Distribution is of shares of Common Stock (or common stock) (“Other Shares of Common Stock”)
of a company whose shares of common stock are traded on a national securities exchange or a national automated quotation system,
then the Holder may elect to receive a warrant to purchase Other Shares of Common Stock in lieu of an increase in the number of
Warrant Shares, the terms of which shall be identical to those of this Warrant, except that such warrant shall be exercisable into
the number of shares of Other Shares of Common Stock that would have been payable to the Holder pursuant to the Distribution had
the Holder exercised this Warrant immediately prior to such record date and with an aggregate exercise price equal to the product
of the amount by which the exercise price of this Warrant was decreased with respect to the Distribution pursuant to the terms
of the immediately preceding paragraph (a) and the number of Warrant Shares calculated in accordance with the first part of this
paragraph (b).

 

4.  PURCHASE
RIGHTS; FUNDAMENTAL TRANSACTIONS.

 

(a) Purchase Rights.
In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or sells any Options, Convertible
Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares
of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of
shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on the exercise of
this Warrant) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or,
if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant,
issue or sale of such Purchase Rights.

 

     

     

    

 

(b) Fundamental
Transactions. The Company shall not enter into or be party to a Fundamental Transaction unless the Successor Entity assumes
this Warrant in accordance with the provisions of this Section (4)(b), including agreements to deliver to each holder of Warrants
in exchange for such Warrants a security of the Successor Entity evidenced by a written instrument substantially similar in form
and substance to this Warrant, including, without limitation, an adjusted exercise price equal to the value for the shares of Common
Stock reflected by the terms of such Fundamental Transaction, and exercisable for a corresponding number of shares of capital stock
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations
on the exercise of this Warrant) prior to such Fundamental Transaction, and satisfactory to the Holder. Upon the occurrence of
any Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of
such Fundamental Transaction, the provisions of this Warrant referring to the “Company” shall refer instead to the
Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company
under this Warrant with the same effect as if such Successor Entity had been named as the Company herein. Upon consummation of
the Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation that there shall be issued upon exercise
of this Warrant at any time after the consummation of the Fundamental Transaction, in lieu of the shares of the Common Stock (or
other securities, cash, assets or other property) purchasable upon the exercise of the Warrant prior to such Fundamental Transaction,
such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription
rights) which the Holder would have been entitled to receive upon the happening of such Fundamental Transaction had this Warrant
been converted immediately prior to such Fundamental Transaction, as adjusted in accordance with the provisions of this Warrant.
In addition to and not in substitution for any other rights hereunder, prior to the consummation of any Fundamental Transaction
pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to or in exchange
for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to insure that
the Holder will thereafter have the right to receive upon an exercise of this Warrant at any time after the consummation of the
Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the Common Stock (or other securities, cash,
assets or other property) purchasable upon the exercise of the Warrant prior to such Fundamental Transaction, such shares of stock,
securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription rights) which the
Holder would have been entitled to receive upon the happening of such Fundamental Transaction had the Warrant been exercised immediately
prior to such Fundamental Transaction. If holders of Common Stock are given any choice as to the securities, cash or property to
be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the consideration it receives upon
any exercise of this Warrant following such Fundamental Transaction. The provisions of this Section 4 shall apply similarly and
equally to successive Fundamental Transactions and Corporate Events and shall be applied without regard to any limitations on the
exercise of this Warrant.

 

5.  NONCIRCUMVENTION.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws or
through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities,
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will
at all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights
of the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares
of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such
actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable
shares of Common Stock upon the exercise of this Warrant, and (iii) shall, so long as this Warrant is outstanding, take all action
necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting
the exercise of this Warrant, 100% of the number of shares of Common Stock issuable upon exercise of this Warrant then outstanding
(without regard to any limitations on exercise).

 

6.  WARRANT
HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in such Person’s
capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital
of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in
such Person’s capacity as the Holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote,
give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation,
merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to
the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant.
In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities
(upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company
or by creditors of the Company.

 

     

     

    

 

7.  REISSUANCE
OF WARRANTS.

 

(a)  Transfer
of Warrant. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company together with a written
assignment of this Warrant in the form attached hereto as Exhibit B duly executed by the Holder or its agent or attorney, whereupon
the Company will forthwith, subject to compliance with any applicable securities laws, issue and deliver upon the order of the
Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder may request, representing the right to purchase
the number of Warrant Shares being transferred by the Holder and, if less than the total number of Warrant Shares then underlying
this Warrant is being transferred, a new Warrant (in accordance with Section 7(d)) to the Holder representing the right to purchase
the number of Warrant Shares not being transferred.

 

(b) Lost, Stolen
or Mutilated Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Warrant, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder
to the Company in customary form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall
execute and deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant
Shares then underlying this Warrant.

 

(c) Exchangeable
for Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the
Company, for a new Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the
number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion
of such Warrant Shares as is designated by the Holder at the time of such surrender; provided, however, that no Warrants for fractional
shares of Common Stock shall be given.

 

(d) Issuance of
New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant
(i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to
purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a)
or Section 7(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying
the other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this
Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant, which is the same as the Issuance Date,
and (iv) shall have the same rights and conditions as this Warrant.

 

8. OPTIONAL REDEMPTION. Beginning
on October 1, 2020, at any time within 10 days following the occurrence of a Trading Threshold (as defined in Section 16(q)), the
Company shall be entitled to redeem the Warrants, or any of them, at a per Warrant Share redemption price of $0.0001 (the “Redemption
Price”), upon 30 days’ written notice to the Holder. Hereinafter such 30-day period, as it may be extended pursuant
to this Section 8, is referred to as the “Redemption Period.” Upon the expiration of the Redemption Period (the
“Redemption Date”), all Warrants noticed for redemption that have not theretofore been exercised by the Holder
shall, upon payment of the aggregate Redemption Price therefor, cease to represent the right to purchase any shares of Common Stock
and shall be deemed cancelled and void and of no further force or effect without any further act or deed on the part of the Company.
The Holder undertakes to return the certificate representing any redeemed Warrants to the Company upon their redemption and to
indemnify the Company with respect to any losses, claims, damages or liabilities arising from the Holder’s failure to return
such certificate. In the event the certificate so returned represents a number of Warrants in excess of the number being redeemed,
the Company shall as promptly as practicable issue to the Holder a new certificate for the number of unredeemed Warrants.

 

     

     

    

 

9. NOTICES.The Company shall
provide the Holder with prompt written notice of all actions taken pursuant to this Warrant, including in reasonable detail a description
of such action and the reason therefor. Whenever notice is required to be given under this Warrant, unless otherwise provided herein,
such notice shall be given in writing, will be mailed (a) if within the domestic United States by first-class registered or certified
mail, or nationally recognized overnight express courier, postage prepaid, or by facsimile or (b) if delivered from outside the
United States, by International Federal Express or facsimile, and (c) will be deemed given (i) if delivered by first-class registered
or certified mail domestic, three business days after so mailed, (ii) if delivered by nationally recognized overnight carrier,
one business day after so mailed, (iii) if delivered by International Federal Express, two business days after so mailed and (iv)
if delivered by facsimile, upon electronic confirmation of receipt, and will be delivered and addressed as follows:

 

	 	(a) 	if to the Company, to:

 

Generation Hemp, Inc.

P.O. Box 540308

Dallas, Texas 75354

Attention: Gary C. Evans

Email: gevans@genhempinc.com

 

with copies to:

 

Duane Morris LLP

1540 Broadway

New York, NY 10036-4086

Attention: Dean M. Colucci

Email: dmcolucci@duanemorris.com

 

	 	(b)	if to the Holder, to:

 

[INSERT NAME AND ADDRESS]

Attn:

Facsimile:

 

with copies to:

 

[ ]

Attn:

Email:

 

or to Holder’s address on any Exercise
Notice delivered to the Company in the form attached as Exhibit A hereto, or at such other address or addresses as may have been
furnished to the Company in writing.

 

10. AMENDMENT AND WAIVER. Except as otherwise
provided herein, the provisions of this Warrant may be amended only with the written consent of the Company and the Holder, and
the Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only with
the written consent of the Holder.

 

11. GOVERNING LAW. This Warrant shall be governed
by and construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance
of this Warrant shall be governed by, the internal laws of the State of Colorado, without giving effect to any choice of law or
conflict of law provision or rule (whether of the State of Colorado or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of Colorado.

 

     

     

    

 

12. CONSTRUCTION; HEADINGS.
This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any person
as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect the
interpretation of, this Warrant.

 

13. DISPUTE RESOLUTION. In
the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company
shall submit the disputed determinations or arithmetic calculations via facsimile or electronic mail within two (2) Business Days
of receipt of the Exercise Notice giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company
are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three Business Days
of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two (2)
Business Days submit via facsimile or electronic mail (a) the disputed determination of the Exercise Price to an independent, reputable
investment bank selected by the Company and approved by the Holder or (b) the disputed arithmetic calculation of the Warrant Shares
to the Company’s independent, outside accountant. The Company shall cause at its expense the investment bank or the accountant,
as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later
than ten Business Days from the time it receives the disputed determinations or calculations. Such investment bank’s or accountant’s
determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error.

 

14. REMEDIES, OTHER OBLIGATIONS,
BREACHES AND INJUNCTIVE RELIEF.  The remedies provided in this Warrant shall be cumulative and in addition to all other
remedies available under this Warrant, at law or in equity (including a decree of specific performance and/or other injunctive
relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply
with the terms of this Warrant.

 

15. TRANSFER. Subject to compliance with any
applicable securities laws, this Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company.

 

16.  CERTAIN
DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

 

(a) “Bloomberg”
means Bloomberg Financial Markets.

 

(b) “Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed.

 

(c) “Change
of Control” means any Fundamental Transaction other than (A) any reorganization, recapitalization or reclassification
of the Common Stock, in which holders of the Company’s voting power immediately prior to such reorganization, recapitalization
or reclassification continue after such reorganization, recapitalization or reclassification to hold publicly traded securities
and, directly or indirectly, the voting power of the surviving entity or entities necessary to elect a majority of the members
of the board of directors (or their equivalent if other than a corporation) of such entity or entities, or (B) pursuant to a migratory
merger effected solely for the purpose of changing the jurisdiction of incorporation of the Company.

 

     

     

    

 

(d) “Closing Bid Price”
and “Closing Sale Price” means, for any security as of any date, the last closing bid price and last closing
trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins
to operate on an extended hours basis and does not designate the closing bid price or the closing trade price, as the case may
be, then the last bid price or the last trade price, respectively, of such security prior to 4:00:00 p.m., New York time, as reported
by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the last
closing bid price or last trade price, respectively, of such security on the principal securities exchange or trading market where
such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last
trade price, respectively, of such security in the over-the-counter market on the electronic bulletin board for such security as
reported by Bloomberg, or, if no closing bid price or last trade price, respectively, is reported for such security by Bloomberg,
the average of the bid prices, or the ask prices, respectively, of any market makers for such security as reported in the “pink
sheets” by Pink Sheets LLC (formerly the National Quotation Bureau, Inc.). If the Closing Bid Price or the Closing Sale Price
cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale
Price, as the case may be, of such security on such date shall be the fair market value as determined by the Board of Directors
of the Company in the exercise of its good faith judgment. All such determinations to be appropriately adjusted for any stock dividend,
stock split, stock combination or other similar transaction during the applicable calculation period.

 

(e) “Common Stock” means
(i) the Company’s shares of Common Stock, par value $0.001 per share, and (ii) any share capital into which such Common Stock
shall have been changed or any share capital resulting from a reclassification of such Common Stock.

 

(f) “Eligible Market”
means the Principal Market, The New York Stock Exchange, Inc., The American Stock Exchange, The NASDAQ Global Select Market, The
NASDAQ Global Market or OTC Bulletin Board.

 

(g) “Expiration Date”
means the date two (2) years following the Issuance Date or, if such date falls on a day other than a Business Day or on which
trading does not take place on the Principal Market (a “Holiday”), the next date that is not a Holiday.

 

(h) “Fundamental Transaction”
means that the Company shall, directly or indirectly, in one or more related transactions, (i) consolidate or merge with or into
(whether or not the Company is the surviving corporation) another Person, or (ii) sell, assign, transfer, convey or otherwise dispose
of all or substantially all of the properties or assets of the Company to another Person, or (iii) allow another Person to make
a purchase, tender or exchange offer that is accepted by the holders of more than the 67% of the outstanding shares of Common Stock
(not including any shares of Common Stock held by the Person or Persons making or party to, or associated or affiliated with the
Persons making or party to, such purchase, tender or exchange offer), or (iv) consummate a stock purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another
Person whereby such other Person acquires more than the 67% of the outstanding shares of Common Stock (not including any shares
of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock purchase agreement or other business combination), (v) reorganize, recapitalize or reclassify its
Common Stock, or (vi) any “person” or “group” (as these terms are used for purposes of Sections 13(d) and
14(d) of the Exchange Act) is or shall become the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act),
directly or indirectly, of 67% of the aggregate ordinary voting power represented by issued and outstanding Common Stock.

 

     

     

    

 

(i) “Parent Entity”
of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity
security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent
Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.

 

(j) “Person” means an
individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and a government or any department or agency thereof.

 

(k) “Principal Market”
means OTC Markets.

 

(l) “Successor Entity”
means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental Transaction
or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been entered
into.

 

(m) “Trading Day” means
any day on which shares of Common Stock are traded on the Principal Market, or, if the Principal Market is not the principal trading
market for the Common Stock, then on the principal securities exchange or securities market or electronic quotations system on
which the shares of Common Stock are then traded; provided that “Trading Day” shall not include any day on which
the Common Stock is scheduled to trade on such exchange, market or system for less than 4.5 hours or any day that the Common Stock
is suspended from trading during the final hour of trading on such exchange, market or system (or if such exchange, market or system
does not designate in advance the closing time of trading on such exchange, market or system, then during the hour ending at 4:00
p.m., New York time).

 

(n) A “Trading Threshold”
shall be deemed to occur on any date that the reported Weighted Average Price for any five (5) out of seven (7) consecutive Trading
Days immediately prior to such date, exceeds $1.00 with a minimum average daily trading volume for such seven (7) day period of
at least 25,000 shares of Common Stock as reported by the Principal Market for such period (with such price and volume criteria
being appropriately adjusted for any share dividend, share split or other similar transaction that may occur on or after the Issuance
Date).

 

(o) “Weighted Average Price”
means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market (or,
if the Principal Market is not the principal trading market for the Common Stock, then on the principal securities exchange or
securities market or electronic quotations system on which the shares of Common Stock are then traded) during the period beginning
at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg through its “Volume
at Price” function or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the
over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York
City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg, or, if no dollar volume-weighted average price
is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing
ask price of any of the market makers for such security as reported in the “pink sheets” by OTC Markets LLC (or any
successor thereto). If the Weighted Average Price cannot be calculated for such security on such date on any of the foregoing bases,
the Weighted Average Price of such security on such date shall be the fair market value as mutually determined by the Company and
the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall
be resolved pursuant to Section 13 with the term “Weighted Average Price” being substituted for the term “Exercise
Price.” All such determinations shall be appropriately adjusted for any share dividend, share split or other similar transaction
during such period.

 

[Signature Page Follows]

 

     

     

    

 

 

IN WITNESS WHEREOF, the parties have
caused this Warrant to Purchase Common Stock to be duly executed and delivered as of the Issuance Date set out above.

 

	 	GENERATION HEMP, INC.
	 	 
	 	
        

        By:
	 
	 	Name: 	Gary C. Evans
	 	Title: 	Chief Executive Officer

 

	 	[TRANSFEROR]
	 	 
	 	
        

        By:
	 
	 	Name: 
	 	
        Title:

        Date: 11-27-2019

 

     

     

    

 

EXHIBIT A

 

EXERCISE NOTICE

 

TO BE EXECUTED BY THE REGISTERED HOLDER
TO EXERCISE THIS

WARRANT TO PURCHASE COMMON STOCK

 

GENERATION HEMP, INC.

 

The undersigned holder hereby exercises the right to purchase
_________________ of the shares of Common Stock (“Warrant Shares”) of Generation Hemp, Inc, a Colorado corporation
(the “Company”), evidenced by the attached Warrant to Purchase Common Stock (the “Warrant”).
Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

 

1.  Form of Exercise
Price. The Holder intends that payment of the Exercise Price shall be made as:

 

	 	____________	a “Cash Exercise” with respect to _________________ Warrant Shares; and/or

 

	 	____________	a “Cashless Exercise” with respect to _______________ Warrant Shares (provided the conditions for cashless exercise set forth in Section 1(d) of the Warrant are satisfied).

 

2.  Payment of Exercise
Price. In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be issued
pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in accordance
with the terms of the Warrant.

 

3.  Delivery of
Warrant Shares. The Company shall deliver __________ Warrant Shares in the name of the undersigned holder or in the name of
______________________ in accordance with the terms of the Warrant or by physical delivery of a certificate to:

 

_______________________________

 

_______________________________

 

_______________________________

 

Date: _______________ __, ______

 

	 	 
	Name of Registered Holder

 

	By:	 	 
	 	Name:
	 	Title:

 

     

     

    

 

ACKNOWLEDGMENT

 

The
Company hereby acknowledges this Exercise Notice and hereby directs [●]
to issue the above indicated number of shares of Common Stock in accordance with the Transfer Agent Instructions dated [ ], 2020
from the Company and acknowledged and agreed to [●].

 

	 	GENERATION HEMP, INC
	 	 
	 	
        By: 
	
	 	 	Name: 	Gary C. Evans 
	 	 	Title:	Chairman and CEO  

 

     

     

    

 

EXHIBIT B

 

ASSIGNMENT FORM

 

(To assign the foregoing warrant, execute

this form and supply required information.

Do not use this form to exercise the warrant.)

 

FOR VALUE RECEIVED, all of or [_______]
shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

_______________________________________________ whose address
is

 

_______________________________________________________________.

 

_______________________________________________________________

 

Dated: ______________, _______

 

	 	Holder’s Signature:	 	 
	 	 	 	 
	 	Holder’s Address:	 	 
	 	 	 	 

 

	Signature Guaranteed:	 	 

 

 

NOTE: The signature to this
Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any
change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary
or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

 

     

     

    

 

EXHIBIT B

 

FORM OF CASH WARRANT

 

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY
IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF
WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.

 

GENERATION HEMP, INC.

 

WARRANT TO PURCHASE COMMON STOCK

(Cash Exercise)

 

Warrant No.: ___

Number of Shares of Common Stock: 3

Date of Issuance: November 27, 2019 (“Issuance Date”)

 

Generation
Hemp, Inc., a Colorado corporation (the “Company”), hereby certifies that, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, [ ● ],
the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set
forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon surrender of this Warrant
to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the
“Warrant”), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time, on
the Expiration Date (as defined below), 3  (three) fully paid non-assessable shares of Common Stock (as defined below) (the
“Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings
set forth in Section 16. This Warrant is the Warrant to purchase Common Stock (this “Warrant”) issued pursuant
to Section 1(a) of that certain Securities Exchange Agreement (the “Securities Exchange Agreement”), dated as
of this date (the “Exchange Date”), by and between the Company and the Transferors (as defined therein).

 

     

     

    

 

1.  EXERCISE OF
WARRANT.

 

(a) Mechanics
of Exercise. Subject to the terms and conditions hereof, this Warrant may be exercised by the Holder on any day on or after
the thirtieth (30th) day after the Issuance Date, in whole or in part, by (i) delivery of a written notice, in the form
attached hereto as Exhibit A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant
and (ii) (A) payment to the Company of an amount equal to the applicable Exercise Price multiplied by the number of Warrant Shares
as to which this Warrant is being exercised (the “Aggregate Exercise Price”) in cash or by wire transfer of
immediately available funds or (B) provided the conditions for cashless exercise set forth in Section 1(d) are satisfied, by notifying
the Company that this Warrant is being exercised pursuant to a Cashless Exercise (as defined in Section 1(d)). The Holder shall
not be required to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise
Notice with respect to less than all of the Warrant Shares shall have the same effect as cancellation of the original Warrant and
issuance of a new Warrant evidencing the right to purchase the remaining number of Warrant Shares. On or before the first (1st
) Business Day following the date on which the Company has received each of the Exercise Notice and the Aggregate Exercise Price
(or notice of a Cashless Exercise) (collectively, the “Exercise Delivery Documents”), the Company shall transmit
by facsimile or electronic mail an acknowledgment of receipt of the Exercise Delivery Documents to the Holder and Continental Stock
Transfer & Trust Company (the Company’s “Transfer Agent”). On or before the third (3rd) Business Day
following the date on which the Company has received all of the Exercise Delivery Documents (the “Share Delivery Date”),
the Company shall cause the Shares to be issued in the name of and delivered to the Holder (i) written confirmation that the Shares
have been issued in the name of the Holder, and (ii) a new warrant of like tenor to purchase all of the Shares that may be purchased
pursuant to the portion, if any, of this Warrant not exercised by the Holder. No fractional shares of Common Stock are to be issued
upon the exercise of this Warrant, but rather the number of shares of Common Stock to be issued shall be rounded down to the nearest
whole number.

 

(b) Exercise
Price. For purposes of this Warrant, “Exercise Price” means $0.352 subject to adjustment as provided
herein.

 

(c) Legend.
The Holder acknowledges that each certificate evidencing the Warrant Shares acquired upon the exercise of this Warrant will
have restrictions upon resale imposed by state and federal securities laws. Each such certificate shall be stamped or imprinted
with a legend substantially in the following form:

 

THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES
LAWS OF ANY STATE AND MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER APPLICABLE FEDERAL
AND STATE SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO SUCH EFFECT, WHICH OPINION SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.

 

     

     

    

 

(d) Beneficial
Ownership. The Company shall not effect the exercise of this Warrant, and the Holder shall not have the right to exercise this
Warrant, to the extent that after giving effect to such exercise, such Person (together with such Person’s affiliates) would
beneficially own in excess of 9.99% (the “Maximum Percentage”) of the shares of Common Stock outstanding immediately
after giving effect to such exercise (including in connection with any Fundamental Transaction (as defined below)). For purposes
of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such Person and its affiliates
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination
of such sentence is being made, but shall exclude shares of Common Stock which would be issuable upon (i) exercise of the remaining,
unexercised portion of this Warrant beneficially owned by such Person and its affiliates and (ii) exercise or conversion of the
unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person and its affiliates
(including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion
or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph,
beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended. For
purposes of this Warrant, in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of
outstanding shares of Common Stock as reflected in (1) the Company’s most recent Form 10-K, Form 10-Q, Current Report on
Form 8-K or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement
by the Company or (3) any other notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock
outstanding. To the extent that the limitation contained in this Section 1(f) applies, the determination of whether this Warrant
is exercisable (in relation to other securities owned by such Holder) and of which a portion of this Warrant is exercisable shall
be in the sole discretion of a Holder, and the submission of an Exercise Notice shall be deemed to be each Holder’s determination
of whether this Warrant is exercisable (in relation to other securities owned by such Holder) and of which portion of this Warrant
is exercisable, in each case subject to such aggregate percentage limitation, and the Company shall have no obligation to verify
or confirm the accuracy of such determination. For any reason at any time, upon the written or oral request of the Holder, the
Company shall within two (2) Business Days confirm to the Holder the number of shares of Common Stock then outstanding. In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder and its affiliates since the date as of which such number of outstanding
shares of Common Stock was reported. By written notice to the Company, the Holder may from time to time increase or decrease the
Maximum Percentage to any other percentage not in excess of 9.99% specified in such notice; provided that (i) any such increase
will not be effective until the sixty-first (61st) day after such notice is delivered to the Company, and (ii) any such increase
or decrease will apply only to the Holder. The provisions of this paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 1(g) to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended beneficial ownership limitation herein contained or to make changes or supplements necessary
or desirable to properly give effect to such limitation.

 

2.  ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price and the number of Warrant Shares shall be adjusted from
time to time as follows:

 

(a) Adjustment upon
Subdivision or Combination of Common Stock. If the Company at any time on or after the Exchange Date subdivides (by any
stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or otherwise) one or more classes of its outstanding
shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to such subdivision will
be proportionately reduced and the number of Warrant Shares will be proportionately increased. If the Company at any time on or
after the Exchange Date combines (by any stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or
otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in
effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately
decreased. Any adjustment under this Section 2(a) shall become effective at the close of business on the date the subdivision or
combination becomes effective.

 

(b) Other Events.
If any event occurs of the type contemplated by the provisions of this Section 2 but not expressly provided for by such provisions
(including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features),
then the Company’s Board of Directors will make an appropriate adjustment in the Exercise Price and the number of Warrant
Shares so as to protect the rights of the Holder; provided that no such adjustment pursuant to this Section 2(b) will increase
the Exercise Price or decrease the number of Warrant Shares as otherwise determined pursuant to this Section 2 .

 

     

     

    

 

3. RIGHTS UPON DISTRIBUTION OF ASSETS.
If the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to
all holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution
of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this
Warrant, then, in each such case:

 

(a) any Exercise Price
in effect immediately prior to the close of business on the record date fixed for the determination of holders of shares of Common
Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such record date, to a price
determined by multiplying such Exercise Price by a fraction of which (i) the numerator shall be the Closing Bid Price of the shares
of Common Stock on the Trading Day immediately preceding such record date minus the value of the Distribution (as determined in
good faith by the Company’s Board of Directors) applicable to one share of Common Stock, and (ii) the denominator shall be
the Closing Bid Price of the shares of Common Stock on the Trading Day immediately preceding such record date; and

 

(b) the number of Warrant
Shares shall be increased to a number of shares equal to the number of shares of Common Stock obtainable immediately prior to the
close of business on the record date fixed for the determination of holders of shares of Common Stock entitled to receive the Distribution
multiplied by the reciprocal of the fraction set forth in the immediately preceding paragraph (a); provided that in the
event that the Distribution is of shares of Common Stock (or common stock) (“Other Shares of Common Stock”)
of a company whose shares of common stock are traded on a national securities exchange or a national automated quotation system,
then the Holder may elect to receive a warrant to purchase Other Shares of Common Stock in lieu of an increase in the number of
Warrant Shares, the terms of which shall be identical to those of this Warrant, except that such warrant shall be exercisable into
the number of shares of Other Shares of Common Stock that would have been payable to the Holder pursuant to the Distribution had
the Holder exercised this Warrant immediately prior to such record date and with an aggregate exercise price equal to the product
of the amount by which the exercise price of this Warrant was decreased with respect to the Distribution pursuant to the terms
of the immediately preceding paragraph (a) and the number of Warrant Shares calculated in accordance with the first part of this
paragraph (b).

 

4.  PURCHASE
RIGHTS; FUNDAMENTAL TRANSACTIONS.

 

(a) Purchase Rights.
In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or sells any Options, Convertible
Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares
of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of
shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on the exercise of
this Warrant) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or,
if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant,
issue or sale of such Purchase Rights.

 

     

     

    

 

(b) Fundamental
Transactions. The Company shall not enter into or be party to a Fundamental Transaction unless the Successor Entity assumes
this Warrant in accordance with the provisions of this Section (4)(b), including agreements to deliver to each holder of Warrants
in exchange for such Warrants a security of the Successor Entity evidenced by a written instrument substantially similar in form
and substance to this Warrant, including, without limitation, an adjusted exercise price equal to the value for the shares of Common
Stock reflected by the terms of such Fundamental Transaction, and exercisable for a corresponding number of shares of capital stock
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations
on the exercise of this Warrant) prior to such Fundamental Transaction, and satisfactory to the Holder. Upon the occurrence of
any Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of
such Fundamental Transaction, the provisions of this Warrant referring to the “Company” shall refer instead to the
Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company
under this Warrant with the same effect as if such Successor Entity had been named as the Company herein. Upon consummation of
the Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation that there shall be issued upon exercise
of this Warrant at any time after the consummation of the Fundamental Transaction, in lieu of the shares of the Common Stock (or
other securities, cash, assets or other property) purchasable upon the exercise of the Warrant prior to such Fundamental Transaction,
such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription
rights) which the Holder would have been entitled to receive upon the happening of such Fundamental Transaction had this Warrant
been converted immediately prior to such Fundamental Transaction, as adjusted in accordance with the provisions of this Warrant.
In addition to and not in substitution for any other rights hereunder, prior to the consummation of any Fundamental Transaction
pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to or in exchange
for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to insure that
the Holder will thereafter have the right to receive upon an exercise of this Warrant at any time after the consummation of the
Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the Common Stock (or other securities, cash,
assets or other property) purchasable upon the exercise of the Warrant prior to such Fundamental Transaction, such shares of stock,
securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription rights) which the
Holder would have been entitled to receive upon the happening of such Fundamental Transaction had the Warrant been exercised immediately
prior to such Fundamental Transaction. If holders of Common Stock are given any choice as to the securities, cash or property to
be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the consideration it receives upon
any exercise of this Warrant following such Fundamental Transaction. The provisions of this Section 4 shall apply similarly and
equally to successive Fundamental Transactions and Corporate Events and shall be applied without regard to any limitations on the
exercise of this Warrant.

 

5.  NONCIRCUMVENTION.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws or
through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities,
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will
at all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights
of the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares
of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such
actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable
shares of Common Stock upon the exercise of this Warrant, and (iii) shall, so long as this Warrant is outstanding, take all action
necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting
the exercise of this Warrant, 100% of the number of shares of Common Stock issuable upon exercise of this Warrant then outstanding
(without regard to any limitations on exercise).

 

     

     

    

 

6.  WARRANT
HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in such Person’s
capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital
of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in
such Person’s capacity as the Holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote,
give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation,
merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to
the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant.
In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities
(upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company
or by creditors of the Company.

 

7.  REISSUANCE
OF WARRANTS.

 

(a)  Transfer
of Warrant. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company together with a written
assignment of this Warrant in the form attached hereto as Exhibit B duly executed by the Holder or its agent or attorney, whereupon
the Company will forthwith, subject to compliance with any applicable securities laws, issue and deliver upon the order of the
Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder may request, representing the right to purchase
the number of Warrant Shares being transferred by the Holder and, if less than the total number of Warrant Shares then underlying
this Warrant is being transferred, a new Warrant (in accordance with Section 7(d)) to the Holder representing the right to purchase
the number of Warrant Shares not being transferred.

 

(b) Lost, Stolen
or Mutilated Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Warrant, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder
to the Company in customary form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall
execute and deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant
Shares then underlying this Warrant.

 

(c) Exchangeable
for Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the
Company, for a new Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the
number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion
of such Warrant Shares as is designated by the Holder at the time of such surrender; provided, however, that no Warrants for fractional
shares of Common Stock shall be given.

 

(d) Issuance of
New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant
(i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to
purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a)
or Section 7(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying
the other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this
Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant, which is the same as the Issuance Date,
and (iv) shall have the same rights and conditions as this Warrant.

 

     

     

    

 

8. OPTIONAL REDEMPTION. Beginning
on October 1, 2020, at any time within 10 days following the occurrence of a Trading Threshold (as defined in Section 16(q)), the
Company shall be entitled to redeem the Warrants, or any of them, at a per Warrant Share redemption price of $0.0001 (the “Redemption
Price”), upon 30 days’ written notice to the Holder. Hereinafter such 30-day period, as it may be extended pursuant
to this Section 8, is referred to as the “Redemption Period.” Upon the expiration of the Redemption Period (the
“Redemption Date”), all Warrants noticed for redemption that have not theretofore been exercised by the Holder
shall, upon payment of the aggregate Redemption Price therefor, cease to represent the right to purchase any shares of Common Stock
and shall be deemed cancelled and void and of no further force or effect without any further act or deed on the part of the Company.
The Holder undertakes to return the certificate representing any redeemed Warrants to the Company upon their redemption and to
indemnify the Company with respect to any losses, claims, damages or liabilities arising from the Holder’s failure to return
such certificate. In the event the certificate so returned represents a number of Warrants in excess of the number being redeemed,
the Company shall as promptly as practicable issue to the Holder a new certificate for the number of unredeemed Warrants.

 

9. NOTICES.The Company
shall provide the Holder with prompt written notice of all actions taken pursuant to this Warrant, including in reasonable detail
a description of such action and the reason therefor. Whenever notice is required to be given under this Warrant, unless otherwise
provided herein, such notice shall be given in writing, will be mailed (a) if within the domestic United States by first-class
registered or certified mail, or nationally recognized overnight express courier, postage prepaid, or by facsimile or (b) if delivered
from outside the United States, by International Federal Express or facsimile, and (c) will be deemed given (i) if delivered by
first-class registered or certified mail domestic, three business days after so mailed, (ii) if delivered by nationally recognized
overnight carrier, one business day after so mailed, (iii) if delivered by International Federal Express, two business days after
so mailed and (iv) if delivered by facsimile, upon electronic confirmation of receipt, and will be delivered and addressed as follows:

 

	 	(a) 	if to the Company, to:

 

Generation Hemp, Inc.

P.O. Box 540308

Dallas, Texas 75354

Attention: Gary C. Evans

Email: gevans@genhempinc.com

 

with copies to:

 

Duane Morris LLP

1540 Broadway

New York, NY 10036-4086

Attention: Dean M. Colucci

Email: dmcolucci@duanemorris.com

 

	 	(b)	if to the Holder, to:

 

[INSERT NAME AND ADDRESS]

Attn:

Facsimile:

 

with copies to:

 

[ ]

Attn:

Email:

 

or to Holder’s address on any Exercise
Notice delivered to the Company in the form attached as Exhibit A hereto, or at such other address or addresses as may have been
furnished to the Company in writing.

 

10. AMENDMENT AND WAIVER. Except as otherwise
provided herein, the provisions of this Warrant may be amended only with the written consent of the Company and the Holder, and
the Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only with
the written consent of the Holder.

 

11. GOVERNING LAW. This Warrant shall be governed
by and construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance
of this Warrant shall be governed by, the internal laws of the State of Colorado, without giving effect to any choice of law or
conflict of law provision or rule (whether of the State of Colorado or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of Colorado.

 

     

     

    

 

12. CONSTRUCTION; HEADINGS.
This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any person
as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect the
interpretation of, this Warrant.

 

13. DISPUTE RESOLUTION. In
the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company
shall submit the disputed determinations or arithmetic calculations via facsimile or electronic mail within two (2) Business Days
of receipt of the Exercise Notice giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company
are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three Business Days
of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two (2)
Business Days submit via facsimile or electronic mail (a) the disputed determination of the Exercise Price to an independent, reputable
investment bank selected by the Company and approved by the Holder or (b) the disputed arithmetic calculation of the Warrant Shares
to the Company’s independent, outside accountant. The Company shall cause at its expense the investment bank or the accountant,
as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later
than ten Business Days from the time it receives the disputed determinations or calculations. Such investment bank’s or accountant’s
determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error.

 

14. REMEDIES, OTHER OBLIGATIONS,
BREACHES AND INJUNCTIVE RELIEF.  The remedies provided in this Warrant shall be cumulative and in addition to all other
remedies available under this Warrant, at law or in equity (including a decree of specific performance and/or other injunctive
relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply
with the terms of this Warrant.

 

15. TRANSFER. Subject to compliance with any
applicable securities laws, this Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company.

 

16.  CERTAIN
DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

 

(a) “Bloomberg”
means Bloomberg Financial Markets.

 

(b) “Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed.

 

(c) “Change
of Control” means any Fundamental Transaction other than (A) any reorganization, recapitalization or reclassification
of the Common Stock, in which holders of the Company’s voting power immediately prior to such reorganization, recapitalization
or reclassification continue after such reorganization, recapitalization or reclassification to hold publicly traded securities
and, directly or indirectly, the voting power of the surviving entity or entities necessary to elect a majority of the members
of the board of directors (or their equivalent if other than a corporation) of such entity or entities, or (B) pursuant to a migratory
merger effected solely for the purpose of changing the jurisdiction of incorporation of the Company.

 

     

     

    

 

(d) “Closing Bid Price”
and “Closing Sale Price” means, for any security as of any date, the last closing bid price and last closing
trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins
to operate on an extended hours basis and does not designate the closing bid price or the closing trade price, as the case may
be, then the last bid price or the last trade price, respectively, of such security prior to 4:00:00 p.m., New York time, as reported
by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the last
closing bid price or last trade price, respectively, of such security on the principal securities exchange or trading market where
such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last
trade price, respectively, of such security in the over-the-counter market on the electronic bulletin board for such security as
reported by Bloomberg, or, if no closing bid price or last trade price, respectively, is reported for such security by Bloomberg,
the average of the bid prices, or the ask prices, respectively, of any market makers for such security as reported in the “pink
sheets” by Pink Sheets LLC (formerly the National Quotation Bureau, Inc.). If the Closing Bid Price or the Closing Sale Price
cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale
Price, as the case may be, of such security on such date shall be the fair market value as determined by the Board of Directors
of the Company in the exercise of its good faith judgment. All such determinations to be appropriately adjusted for any stock dividend,
stock split, stock combination or other similar transaction during the applicable calculation period.

 

(e) “Common Stock” means
(i) the Company’s shares of Common Stock, par value $0.001 per share, and (ii) any share capital into which such Common Stock
shall have been changed or any share capital resulting from a reclassification of such Common Stock.

 

(f) “Eligible Market”
means the Principal Market, The New York Stock Exchange, Inc., The American Stock Exchange, The NASDAQ Global Select Market, The
NASDAQ Global Market or OTC Bulletin Board.

 

(g) “Expiration Date”
means the date two (2) years following the Issuance Date or, if such date falls on a day other than a Business Day or on which
trading does not take place on the Principal Market (a “Holiday”), the next date that is not a Holiday.

 

(h) “Fundamental Transaction”
means that the Company shall, directly or indirectly, in one or more related transactions, (i) consolidate or merge with or into
(whether or not the Company is the surviving corporation) another Person, or (ii) sell, assign, transfer, convey or otherwise dispose
of all or substantially all of the properties or assets of the Company to another Person, or (iii) allow another Person to make
a purchase, tender or exchange offer that is accepted by the holders of more than the 67% of the outstanding shares of Common Stock
(not including any shares of Common Stock held by the Person or Persons making or party to, or associated or affiliated with the
Persons making or party to, such purchase, tender or exchange offer), or (iv) consummate a stock purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another
Person whereby such other Person acquires more than the 67% of the outstanding shares of Common Stock (not including any shares
of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock purchase agreement or other business combination), (v) reorganize, recapitalize or reclassify its
Common Stock, or (vi) any “person” or “group” (as these terms are used for purposes of Sections 13(d) and
14(d) of the Exchange Act) is or shall become the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act),
directly or indirectly, of 67% of the aggregate ordinary voting power represented by issued and outstanding Common Stock.

 

     

     

    

 

(i) “Parent Entity”
of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity
security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent
Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.

 

(j) “Person” means an
individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and a government or any department or agency thereof.

 

(k) “Principal Market”
means OTC Markets.

 

(l) “Successor Entity”
means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental Transaction
or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been entered
into.

 

(m) “Trading Day” means
any day on which shares of Common Stock are traded on the Principal Market, or, if the Principal Market is not the principal trading
market for the Common Stock, then on the principal securities exchange or securities market or electronic quotations system on
which the shares of Common Stock are then traded; provided that “Trading Day” shall not include any day on which
the Common Stock is scheduled to trade on such exchange, market or system for less than 4.5 hours or any day that the Common Stock
is suspended from trading during the final hour of trading on such exchange, market or system (or if such exchange, market or system
does not designate in advance the closing time of trading on such exchange, market or system, then during the hour ending at 4:00
p.m., New York time).

 

(n) A “Trading Threshold”
shall be deemed to occur on any date that the reported Weighted Average Price for any five (5) out of seven (7) consecutive Trading
Days immediately prior to such date, exceeds $1.00 with a minimum average daily trading volume for such seven (7) day period of
at least 25,000 shares of Common Stock as reported by the Principal Market for such period (with such price and volume criteria
being appropriately adjusted for any share dividend, share split or other similar transaction that may occur on or after the Issuance
Date).

 

(o) “Weighted Average Price”
means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market (or,
if the Principal Market is not the principal trading market for the Common Stock, then on the principal securities exchange or
securities market or electronic quotations system on which the shares of Common Stock are then traded) during the period beginning
at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg through its “Volume
at Price” function or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the
over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York
City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg, or, if no dollar volume-weighted average price
is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing
ask price of any of the market makers for such security as reported in the “pink sheets” by OTC Markets LLC (or any
successor thereto). If the Weighted Average Price cannot be calculated for such security on such date on any of the foregoing bases,
the Weighted Average Price of such security on such date shall be the fair market value as mutually determined by the Company and
the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall
be resolved pursuant to Section 13 with the term “Weighted Average Price” being substituted for the term “Exercise
Price.” All such determinations shall be appropriately adjusted for any share dividend, share split or other similar transaction
during such period.

 

[Signature Page Follows]

 

     

     

    

 

 

IN WITNESS WHEREOF, the parties have
caused this Warrant to Purchase Common Stock to be duly executed and delivered as of the Issuance Date set out above.

 

	 	GENERATION HEMP, INC.
	 	 
	 	
        By:
	 
	 	Name: Gary C. Evans
	 	Title: Chief Executive Officer

 

	 	[TRANSFEROR]
	 	 
	 	
        By:
	 
	 	Name: 
	 	
        Title:

        Date:

 

     

     

    

 

EXHIBIT A

 

EXERCISE NOTICE

 

TO BE EXECUTED BY THE REGISTERED HOLDER
TO EXERCISE THIS

WARRANT TO PURCHASE COMMON STOCK

 

GENERATION HEMP, INC.

 

The undersigned holder hereby exercises the right to purchase
_________________ of the shares of Common Stock (“Warrant Shares”) of Generation Hemp, Inc, a Colorado corporation
(the “Company”), evidenced by the attached Warrant to Purchase Common Stock (the “Warrant”).
Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

 

1.  Payment of Exercise
Price. In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be issued
pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in accordance
with the terms of the Warrant.

 

2.  Delivery of
Warrant Shares. The Company shall deliver __________ Warrant Shares in the name of the undersigned holder or in the name of
______________________ in accordance with the terms of the Warrant or by physical delivery of a certificate to:

 

_______________________________

 

_______________________________

 

_______________________________

 

Date: _______________ __, ______

 

	 	 
	Name of Registered Holder

 

	By:	 	 
	 	Name:
	 	Title:

 

     

     

    

 

ACKNOWLEDGMENT

 

The
Company hereby acknowledges this Exercise Notice and hereby directs [●]
to issue the above indicated number of shares of Common Stock in accordance with the Transfer Agent Instructions dated [ ], 2020
from the Company and acknowledged and agreed to [●].

 

	 	GENERATION HEMP, INC
	 	 
	 	
        By:
	 
	 	 	Name:
	 	 	Title:

 

     

     

    

 

EXHIBIT B

 

ASSIGNMENT FORM

 

(To assign the foregoing warrant, execute

this form and supply required information.

Do not use this form to exercise the warrant.)

 

FOR VALUE RECEIVED, all of or [_______]
shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

_______________________________________________ whose address
is

 

_______________________________________________________________.

 

_______________________________________________________________

 

Dated: ______________, _______

 

	 	Holder’s Signature:	 	 
	 	 	 	 
	 	Holder’s Address:	 	 
	 	 	 	 

 

	Signature Guaranteed:	 	 

 

 

NOTE: The signature to this
Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any
change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary
or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

 

     

     

    

 

EXHIBIT C

 

RISK FACTORS

 

[See attached.]

 

     

     

    

 

This investment has a high degree of risk. Before you invest
you should carefully consider the risks and uncertainties described below. If any of the following risk factors actually occur,
our business, operating results and financial condition could be seriously harmed, and the value of our stock could go down. This
means you could lose all or part of your investment.

 

Risks Related to our
Activities in the Legal Hemp Industry 

 

This investment has a high degree of risk. 
Before you invest you should carefully consider the risks and uncertainties described below.  If any of the following risks
actually occur, our business, operating results and financial condition could be harmed, and the value of our stock could go down. 
This means you could lose all or part of your investment.

 

The Hemp space is a completely new and
developing sector with many uncertainties.  The recent legal designation of hemp that distinguishes its plant properties from
marijuana has required ongoing acceptance and the establishment of protocols by certain institutions in which affiliation is required
to conduct business; i.e. banking, insurance, transport.  The lack of established protocols, the continuous changes in developing
protocols, and the effects on businesses operating within the Hemp sector can potentially result in a disruption of workflow, in
sales processing, in freely shipping and receiving of hemp plant material and/or products and receiving the necessary protections/coverages
by insurance.  These evolving elements also potentially create a volatile landscape which can encumber a business’s
ability to make sound decisions, execute on previously planned strategies, or make reliable projections.  Hemp is federally
legal and as of March 2020, is legal in all but two states, Idaho and Mississippi.  Idaho passed the hemp bill in its Senate
in February 2020, but the bill was defeated in its House in March 2020. Each state has the ability to determine its hemp legality,
although broader oversight power is held by the United States Department of Agriculture (USDA) and the Food and Drug Administration
(FDA).  On April 6, 2020, the Drug Enforcement Agency (DEA) descheduled cannabidiol (CBD), one of the cannabinoids that can
be extracted from hemp which has gained widespread attention among consumers and businesses across several markets.  However,
hemp has several other cannabinoids and while there is still limited data and clinical studies on the most popular cannabinoid,
CBD, even less data and fewer clinical studies are available for other cannabinoids.  This lack of data therefore presents
many unknowns that have potential to create an uncertain future pathway for hemp. 

 

Guidelines, standard practices, and regulations
have not been thoroughly established and have undergone several changes in a short amount of time.  This represents one of
the greatest risks that hemp faces for the future.  Companies that create models, build and formulate product lines, and construct
systems and equipment to operate and produce certain outputs based on current guidelines have the potential for those systems,
product lines, etc. to be non-compliant or unusable if regulations and guidelines change to their detriment.

 

The nascency of the Hemp space and a relatively
low barrier to entry for CBD consumer products through white label companies and ecommerce platforms has attracted a wide range
of individuals and professionals to the space.  The potentially high margins for successful hemp crops in comparison to traditional
crops like corn or wheat have also attracted a large number of growers/farmers to the space.  Given the limited amount of
time for individuals and entities to have developed expertise in their efforts within their respective hemp markets, each segment
of the hemp supply chain is potentially susceptible to less than optimal success, quality, and/or performance.  More time
will be necessary to optimize all processes and standards.  This influx of individuals and entities that may not be using
best practices or producing quality crops or products present a potential risk of negatively influencing consumer experience with
hemp and its derivative products or influencing commodity prices of crops with a possible surplus of potentially low-quality biomass. 
These elements could potentially have a negative impact on the consumers’ and investment community’s perception and
embracing of the hemp and CBD market as a whole.

 

     

     

    

 

We will be subject
to a myriad of different laws and regulations governing hemp and our inability to comply with such laws in a cost-effective manner
may have an adverse effect on our business and result of operations.

 

Laws and regulations
governing the use of hemp in the United States are broad in scope; subject to evolving interpretations; and subject to enforcement
by a myriad of regulatory agencies and law enforcement entities. Under the Agriculture Improvement Act of 2018, also known as the
2018 Farm Bill, a state or Indian tribe that desires to have primary regulatory authority over the production of hemp in the state
or territory of the Indian tribe must submit a plan to monitor and regulate hemp production to the Secretary of the USDA. The Secretary
must then approve the state or tribal plan after determining if the plan complies with the requirements set forth in the Agriculture
Improvement Act of 2018. The Secretary may also audit the state or Indian tribe’s compliance with the federally-approved
plan. If the Secretary does not approve the state or Indian tribe’s plan, then the production of hemp in that state or territory
of that Indian tribe will be subject to a plan established by USDA. USDA has not yet established such a plan. We anticipate that
many states will seek to have primary regulatory authority over the production of hemp. States that seek such authority may create
new laws and regulations that limit or restrict the use of hemp.

 

Federal and state laws
and regulations on hemp may address production, monitoring, manufacturing, distribution, and laboratory testing to ensure that
that the hemp has a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis. Federal laws and regulations
may also address the transportation or shipment of hemp or hemp products, as the Agriculture Improvement Act of 2018 prohibits
states and Indian tribes from prohibiting the transportation or shipment of hemp or hemp products produced in accordance with that
law through the state or territory of the Indian tribe, as applicable. We may be subject to many different state-based regulatory
regimens for hemp, all of which could require us to incur substantial costs associated with compliance requirements. Our operations
will be restricted to only where such operations are legal on the local, state and federal levels.

 

In addition, it is
possible that additional regulations may be enacted in the future in the United States and globally that will be directly applicable
to research and development operations.

 

We cannot predict the
nature of any future laws, regulations, interpretations, or applications, nor can we determine what effect additional governmental
regulations or administrative policies and procedures, when and if promulgated, could have on our business.

 

We have no operating
history in the legal hemp or cannabis industry, which makes it difficult to accurately assess our future growth prospects. 

 

The legal hemp and
cannabis industry is an evolving industry that may not develop as expected. Furthermore, our operations will continue to evolve
as we continually assess new strategic opportunities for our business within this industry. Assessing the future prospects of this
industry is challenging in light of both known and unknown risks and difficulties we may encounter.

 

     

     

    

 

Growth prospects in
the legal hemp and cannabis industry can be affected by a wide variety of factors including:

 

		●	Competition from other similar companies;

 

		●	Fluctuations in the market price of CBD oil;

 

		●	Regulatory limitations on the types of research and development with respect to cannabis;

 

		●	Other changes in the regulation of cannabis and legal hemp use; and

 

		●	Changes in underlying consumer behavior, which may affect the demand of our legal hemp and cannabis
traits.

 

We may not be able
to successfully address the above factors, which could negatively impact our intended business plans.

 

Because we have
only recently begun our legal hemp operations, we anticipate our operating expenses will increase prior to earning revenue from
these operations.

 

As we identify and
develop strategic opportunities, conduct any necessary research and development with respect to legal hemp, and expand our operations,
we anticipate significant increases in our operating expenses, and we may not realize significant revenues from such operations.
As a result, the Company may incur significant financial losses with respect to such operations in the foreseeable future. There
is no history upon which to base any assumption as to the likelihood that these operations will prove successful.

 

Negative press
from being in the hemp/cannabis space could have a material adverse effect on our business, financial condition, and results of
operations.

 

The hemp plant and
the cannabis/marijuana plant are both part of the same cannabis sativa genus/species of plant, except that hemp, by definition,
has less than 0.3% THC content, but the same plant with a higher THC content is cannabis/marijuana, which is legal under certain
state laws, but which is not legal under federal law. The similarities between these plants can cause confusion, and our activities
with legal hemp may be incorrectly perceived as us being involved in federally illegal cannabis. Also, despite growing support
for the cannabis industry and legalization of cannabis in certain U.S. states, many individuals and businesses remain opposed to
the cannabis industry. Any negative press resulting from any incorrect perception that we have entered into the cannabis space
could result in a loss of current or future business. It could also adversely affect the public’s perception of us and lead
to reluctance by new parties to do business with us or to own our common stock. We cannot assure you that additional business partners,
including but not limited to financial institutions and customers, will not attempt to end or curtail their relationships with
us. Any such negative press or cessation of business could have a material adverse effect on our business, financial condition,
and results of operations.

 

     

     

    

 

Risks Related to
Our Business 

 

Unfavorable global
economic or political conditions could adversely affect our business, financial condition or results of operations.

 

Our results of operations
could be adversely affected by general conditions in the global economy and in the global financial markets. A global financial
crisis or a global or regional political disruption could cause extreme volatility in the capital and credit markets. For example,
outbreaks of epidemic, pandemic, or contagious diseases, such as the recent COVID-19 outbreak, could disrupt our business. Business
disruptions could include disruptions to the productivity of our employees working remotely and restrictions on their travel may
hinder their ability to meet with potential customers and close transactions, as well as temporary closures of the facilities of
suppliers or contract growers as we try to develop our supply chain. In addition, the COVID-19 outbreak may result in a severe
economic downturn and has already significantly affected the financial markets of many countries. A severe or prolonged economic
downturn or political disruption could result in a variety of risks to our business, including our ability to raise capital when
needed on acceptable terms, if at all. A weak or declining economy or political disruption could also strain our operations, possibly
resulting in a future supply disruption, or cause our future customers to delay making payments for our services. Any of the foregoing
could harm our business and we cannot anticipate all of the ways in which the political or economic climate and financial market
conditions could adversely impact our business.

 

Our Auditor’s report states
that there is substantial doubt that we will be able to continue as a going concern

 

We have had substantial losses since inception and as of December
31, 2019, and have minimal cash reserves. While we are beginning to generate increasing revenue and a positive cash flow, our ability
to build significant cash reserves and continue as a going concern over the long term remains unproven. In the event that we are
forced to reduce operations or seriously curtail our business, an investor will lose all money invested.

 

A significant portion of our previous
monthly cash flow was derived from rental revenue received from our industrial warehouse, which may prove uncollectable.

 

We carefully vet prospective tenants, and we obtain their personal
guarantees as to payment and performance under the lease terms, when deemed necessary.

 

In the event the cultivation business of one or more grower
tenants fails, or for any reason our tenant fails to pay rent in a timely fashion and we do not receive the rent payments as such
payments become due under lease terms, thereafter, if satisfactory payment arrangements as acceptable to us are not made, we may
be forced to evict.

 

Under terms of the leases now in effect, if we do not receive
rent payments as such payments become due and payable under lease terms, we may first utilize the sums we hold as tenant security
deposits to collect the late rent payments with penalty. Under the terms of the leases in place, tenants then are required, within
five days, to replace such security deposit sums such that the full tenant security deposit is restored. There is no assurance
that such replacements of deposit sums will actually occur.

 

In any event, if tenants do not comply with lease terms, and
no workable arrangement can be achieved, we may be forced to evict one or more tenants. This has occurred in the past and could
occur again. Unfavorable developments of this nature could contribute to or cause us to fall behind on our obligations to make
monthly mortgage payments as such payments become due.

 

     

     

    

 

During the past, the Company has experienced disagreements with
certain previous warehouse tenants.  One tenant abandoned his unit and was subsequently evicted. The other tenant ultimately
amended his lease to include the abandoned space but only after considerable argument over various lease terms had been settled. 
As of the date of this report, a single tenant is leasing our entire Garfield Street warehouse and that tenant has remained current
on its lease obligations. 

 

If we pursue an action for eviction,
one or more tenants might cause physical damage to our real estate and/or fight an action for eviction, and/or refuse to vacate
or otherwise undertake to block and/or slow our efforts to regain proper possession of our warehouse or to locate a suitable alternative
tenant to re-lease our warehouse.

 

We believe that we have acted legally and in good faith with
respect to our warehouse tenant(s). We further believe that our real estate is adequately insured. We plan to defend our property
and related contractual rights to the fullest extent of the law.  In the past we were assisted by counsel to negotiate a suitable
remedy to various disputes.  There is no present way to predict the final outcome of any new issues that may arise.

 

A tenant, present or former, may claim to have suffered
damages and in connection with that belief, may elect to initiate and thereafter pursue one or more regulatory complaints or lawsuits
against the Company, its management and subsidiaries.

 

We believe we have acted properly in all of our dealings with
tenants at our warehouse and properties we manage for third parties and otherwise. We have requested counsel to confirm the legality
of our past and present agreements and actions and to advise us accordingly. In any case, we have prevailed in various prior matters
of this nature and we plan to vigorously defend any suit or regulatory complaint brought against the Company, its employees or
agents.

 

We have a limited operating history and operate under
the professional guidance of our Chairman and CEO

 

Our ability to achieve consistent cash flow and profitability
depends upon the continued service of Gary C. Evans. Mr. Evans is our Chairman and CEO, largest shareholder, and one of two management
level executives.

 

Our business plan provides that we will grow the Company’s
asset base and revenues rapidly and ultimately deliver a positive cash flow generating company.

 

We may not be able to generate predictable and continuous revenue
in the future. Further, there is no assurance that we will ever grow operations in the manner contemplated.

 

We may incur significant operating losses in the future, due
to the expansion of our operations or other factors. There is no assurance that we can expand under terms that permit profitable
operations over the long term. Failure to generate sufficient revenue to pay expenses as they come due may make us unable to continue
as a going concern and result in the failure of our company and the complete loss of any money invested to purchase our shares.

 

We may be unable to manage our growth or implement our
expansion strategy.

 

As a public company, our expenses include, but are not limited
to, annual audits, legal costs, SEC reporting costs, costs of a transfer agent and the costs associated with fees and compliance.
Further, our management will need to invest significant time and energy to stay current with the public company responsibilities
of our business and may from time to time have diminished time available to apply to other tasks necessary to our survival and
growth.

 

     

     

    

 

It is therefore possible that the financial and time burdens
of operating as a public company will cause us to fail to achieve profitability. If we exhaust our funds, our business
will fail and our investors will lose all money invested in our stock.

 

If we fail to pay public company costs, as such costs are incurred;
we could become delinquent in our reporting obligations and face the delisting of our shares.

 

It is essential that we grow our overall business, achieve significant
profits and maintain adequate cash flow in order to pay the cost of remaining a public entity which includes but is not limited
the costs of remaining current with SEC reporting obligations.

 

The issuance of additional shares of our common stock
may be necessary for the implementation of our growth strategy.

 

A limited private placement of restricted shares of our common
stock has been completed when deemed necessary. Cash generated in prior years was used to acquire cannabis zoned real property,
finance our office space and provide working capital.  Issuance of any additional securities pursuant to future fundraising
activities undertaken may significantly dilute the ownership of existing shareholders and may reduce the price of our common stock.

 

We acquired, improved and leased our Denver warehouse to a licensed
third party Hemp seed grower. Rental payments are current and the warehouse is presently reflecting positive cash flow.

 

While we have been able to acquire a warehouse in Denver Colorado
with owner financing, future acquisitions may require financial resources well in excess of our present balance sheet. Failure
to successfully obtain additional funding would likely jeopardize our ability to expand our hemp business and related operations. 

 

The loss of our current executive officer or key management
personnel or inability to attract and retain the necessary personnel could have a material adverse effect upon our business, financial
condition or results of operations

 

Our success is heavily dependent on the continued active participation
of our current executive officer, largest shareholder, and sole director listed under "Management." Loss of the services
of Mr. Gary C. Evans, would have a material adverse effect upon our business, financial condition or results of operations. Further,
our success and achievement of our growth plans depend on our ability to recruit, hire, train and retain other highly qualified
technical, professional, clerical, administrative and managerial personnel. Inability to attract and retain the necessary personnel,
consultants and advisors could have a material adverse effect on our business, financial condition or results of operations. 

 

We are controlled by our current officer and director.

 

Gary C. Evans, our Chairman and Chief Executive Officer, who,
as of December 31, 2019, beneficially owns approximately 40% of our outstanding shares of Common Stock. Mr. Evans consequently
controls the election of our Board of Directors and the outcome of issues submitted to our stockholders.

 

     

     

    

 

Since we have only one director who serves as our Chairman,
President, Chief Executive Officer, and Chief Financial Officer, decisions which affect the company will be made by only one individual. It
is likely that conflicts of interest will arise in the day-to- day operations of our business. Such conflicts, if not
properly resolved, could have a material negative impact on our business. 

 

In the past, the Company has issued shares for cash and services
at prices which were solely determined by prior management. At that time, management made a determination of both the value of
the exchange for our shares, and, as well, the price per share used in the capital raising effort.  Transactions of
this nature were not made at arm's length and were made without input from a knowledgeable and non-interested third party. 
Future transactions of a like nature could dilute the percentage ownership of the company owned by a given investor. While the
company believes its past transactions were appropriate, and plans to act in good faith in the future, an investor in our shares
will have no ability to alter such transactions as they may occur in the future and, further, will not be consulted by the company
in advance of any such transactions. An investor who is unwilling to endure such potential dilution should not purchase our shares.

 

Adverse outcomes
in future legal proceedings could subject us to substantial damages and adversely affect our results of operations and profitability.

 

We may become party to
legal proceedings, including matters involving personnel and employment issues, personal injury, environmental matters, and other
proceedings. Some of these potential proceedings could result in substantial damages or payment awards that exceed our insurance
coverage. We will estimate our exposure to any future legal proceedings and establish provisions for the estimated liabilities
where it is reasonably possible to estimate and where an adverse outcome is probable. Assessing and predicting the outcome of these
matters will involve substantial uncertainties. Furthermore, even if the outcome is ultimately in our favor, our costs associated
with such litigation may be material. Adverse outcomes in future legal proceedings or the costs and expenses associated therewith
could have an adverse effect on our results of operations.

 

We will seek
to expand through acquisitions of and investments in various brands, businesses, and assets in the Hemp sector. These acquisition
activities may be unsuccessful or divert management’s attention.

 

We will consider strategic
and complementary acquisitions of and investments in other brands, businesses or other assets in the Hemp sector, and such acquisitions
or investments are subject to risks that could affect our business, including risks related to:

 

		●	the necessity of coordinating geographically disparate organizations;

 

		●	implementing common systems and controls;

 

		●	integrating personnel with diverse business and cultural backgrounds;

 

		●	integrating acquired manufacturing and production facilities, technology and products;

 

		●	unanticipated expenses related to integration, including technical and operational integration;

 

     

     

    

 

		●	increased costs and unanticipated liabilities, including with respect to registration, environmental,
health and safety matters, that may affect sales and operating results;

 

		●	retaining key employees;

 

		●	obtaining required government and third-party approvals;

 

		●	legal limitations in new jurisdictions;

 

		●	installing effective internal controls and audit procedures;

 

		●	issuing common stock that could dilute the interests of our existing stockholders;

 

		●	spending cash and incurring debt;

 

		●	assuming contingent liabilities; and

 

		●	creating additional expenses.

 

We may not be able to
identify opportunities or complete transactions on commercially reasonable terms, or at all, or actually realize any anticipated
benefits from such acquisitions or investments. Similarly, we may not be able to obtain financing for acquisitions or investments
on attractive terms. In addition, the success of any acquisitions or investments also will depend, in part, on our ability to integrate
the acquisition or investment with our then existing operations.

 

We risk insolvency
if revenues decline sharply and we are unable pay our bills and unable to timely locate and negotiate a suitable business combination
or capital injection.

 

Management is always
concerned over potentially unfavorable events and related sharp reductions in revenues. If such problems occur, we will first reduce
expenses, conserve cash and endeavor to replace lost revenue. In anticipation of possible problems of this nature, and alternatively
to grow our business when opportunity presents, management has continued its negotiations in connection with potential business
combinations and continues to explore other means of raising cash. Our goal is to develop cash reserves, either for expansion,
or to cover shortfalls in revenue. Management believes that ultimately, consummation of one or more such transactions would serve
the best interests of shareholders; however, there is no assurance that we can locate or consummate a suitable business combination
or otherwise provide for liquidity, expanded working capital and a stronger balance sheet.

 

     

     

    

 

We are subject to corporate governance and internal control
reporting requirements, and our costs related to compliance with, or our failure to comply with existing and future requirements,
could adversely affect our business.

 

We face corporate governance requirements under the Sarbanes-Oxley
Act of 2002, as well as new rules and regulations subsequently adopted by the SEC and the Public Company Accounting Oversight Board.
These laws, rules and regulations continue to evolve and may become increasingly stringent in the future. In particular, under
new SEC rules we will be required to include management's report on internal controls as part of our annual report pursuant
to Section 404 of the Sarbanes-Oxley Act. Furthermore, under the proposed rules, an attestation report on our internal controls
from our independent registered public accounting firm will be required as part of our annual report. We are in the process of
evaluating our control structure to help ensure that we will be able to comply with Section 404 of the Sarbanes-Oxley Act. The
financial cost of compliance with these laws, rules and regulations is expected to be substantial. We cannot assure you that we
will be able to fully comply with these laws, rules and regulations that address corporate governance, internal control reporting
and similar matters. Failure to comply with these laws, rules and regulations could materially adversely affect our reputation,
financial condition and the value of our securities. 

 

Risks Related to Ownership of Our Common Stock

 

Our stock price has been and may continue to be volatile,
and you could lose all or part of your investment.

 

The market price of our common stock is subject to wide fluctuations
in response to various risk factors, some of which are beyond our control and may not be related to our operating performance,
including:

 

		●	addition or loss of significant customers, suppliers, or distributors;

 

		●	changes in laws or regulations applicable to our industry ;

 

		●	additions or departures of key personnel;

 

		●	the failure of securities analysts to cover our common stock after an offering;

 

		●	actual or anticipated changes in expectations regarding our performance by investors or securities analysts;

 

		●	price and volume fluctuations in the overall stock market;

 

		●	volatility in the market price and trading volume of companies in our industry or companies that investors consider comparable;

 

		●	share price and volume fluctuations attributable to inconsistent trading volume levels of our shares;

 

		●	our ability to protect our intellectual property and other proprietary rights;

 

		●	sales of our common stock by us or our stockholders;

 

		●	the expiration of contractual lock-up agreements;

 

		●	litigation involving us, our industry, or both;

 

		●	major catastrophic events; and

 

		●	general economic and market conditions and trends.

 

     

     

    

 

Further, the stock markets have experienced extreme price and
volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. These fluctuations
often have been unrelated or disproportionate to the operating performance of those companies. In addition, the stock prices of
many cannabis-related companies have experienced wide fluctuations that have often been unrelated to the operating performance
of those companies. These broad market and industry fluctuations, as well as general economic, political, and market conditions
such as recessions, interest rate changes, or international currency fluctuations, may cause the market price of our common stock
to decline. If the market price of our common stock fluctuates or declines, you may not realize any return on your investment and
may lose some or all of your investment.

 

Our operating results will be subject to fluctuations
and our stock price may decline significantly.

 

Our quarterly revenue and operating results will be difficult
to predict from quarter to quarter. We derive relatively stable revenue from our property leased industrial warehouse. Nonetheless,
it is possible that our net operating results in some quarters will fall below our expectations. Our quarterly operating results
will be affected by a number of factors, including:

 

		●	Timing, availability and changes in government incentive programs;

 

		●	Unplanned additional expenses and/or shortfalls in anticipated rental income at our warehouse property;

 

		●	Logistical costs;

 

		●	The timing of new technology announcements or introductions by our competitors and other developments in the competitive environment;

 

		●	Increases or decreases in real estate appreciation rates due to changes in economic growth;

 

		●	Travel costs and other factors; and

 

		●	State and federal government regulations

 

If revenue for a particular quarter is lower than we expect,
we may not be unable to proportionately reduce our operating expenses for that quarter, which would harm our operating results
for that quarter. If we fail to meet investor expectations or our own future guidance, even by a small amount, our stock price
could decline, perhaps substantially.

 

There are restrictions on the transferability of the securities.

 

Until registered for resale, investors must bear the economic
risk of an investment in the Shares for an indefinite period of time. Rule 144 promulgated under the Securities Act ("Rule
144"), which provides for an exemption from the registration requirements under the Securities Act under certain conditions,
requires, among other conditions,a six month holding period prior to the resale (in limited amounts) of securities acquired in
a non-public offering without having to satisfy the registration requirements under the Securities Act. There can be no assurance
that we will fulfill any reporting requirements in the future under the Exchange Act or disseminate to the public any current financial
or other information concerning us.

 

     

     

    

 

A substantial number of our issued shares are or are being
made available for sale on the open market. The resale of these securities might adversely affect our stock price.

 

The sale of a substantial number of shares of our common stock,
or the market's anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in
the future at a time and at a price that we might otherwise obtain.

 

Availability of these shares for sale in the public market could
also impair our ability to raise capital by selling equity securities.

 

There is presently a limited trading market for our shares.
An investment in our shares may be or become totally illiquid and any investor purchasing our shares may be unable to resell their
shares. There can be no assurance that market interest in our shares will develop or continue. Therefore, investors who purchase
our shares could lose their entire investment.

 

Even if significant trading activity involving our shares continues,
the volume of trading may be small and on some days the volume may be zero. Our share price will likely be volatile and will likely
fall rapidly should an investor attempt to liquidate a significant number of shares. These conditions are likely to persist and
could prevent resale of our shares on desirable terms.

 

If the Company uses its stock in acquisitions of other
entities there may be substantial dilution at the time of a transaction.

 

The offering price of the common stock we sold under our prospectus,
and more recently as a private placement of restricted shares of our common stock to raise working capital, was arbitrarily set.
The price did not bear any relationship to our assets, book value, earnings or net worth and it is not an indication of actual
value. You may also suffer additional dilution in the future from the sale of additional shares of common stock or other securities
or if the Company's shares are issued to purchase other assets or to raise additional working capital.

 

There is presently a very limited market for our common
stock. Failure to maintain a trading market could negatively effect the value of our shares and make it difficult or impossible
for you to sell your shares.

 

Our common stock has been assigned a trading symbol, "GENH."
As of December 31, 2109, our common shares are quoted on OTC Pinks Current. There is no cost of such quotation and related services
from OTC Markets, Inc.

 

Trading activity in our shares remains sporadic and there can
be no assurance as to the liquidity of any markets for our common stock, the ability of holders of our common stock to sell our
common stock, or the prices at which holders may be able to sell our common stock. Failure to maintain an active trading market
could negatively affect the value of our shares and make it difficult for you to sell your shares or recover any part of your investment
in our shares. The market price of our common stock may be highly volatile. In addition to the uncertainties relating to our future
operating performance and the profitability of our operations, factors such as variations in our interim financial results, or
various, and as yet unpredictable factors, many of which are beyond our control, may have a negative effect on the market price
of our common stock..

 

     

     

    

 

As an emerging growth company within the meaning of the
Securities Act, we utilize certain modified disclosure requirements, and we cannot be certain if these reduced requirements will
make our common stock less attractive to investors.

 

We are an emerging growth company within the meaning of the
rules under the Securities Act and we utilize the modified disclosure requirements available to emerging growth companies, including
reduced disclosure about our executive compensation and omission of compensation discussion and analysis, and an exemption from
the requirement of holding a nonbinding advisory vote on executive compensation. In addition, we are not subject to certain requirements
of Section 404 of the Sarbanes-Oxley Act, including the additional testing of our internal control over financial reporting as
may occur when outside auditors attest as to our internal control over financial reporting. As a result, our stockholders may not
have access to certain information they may deem important. We cannot predict if investors will find our common stock less attractive
because we rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active
trading market for our common stock and our stock price may be more volatile.

 

Because we do not expect to pay any dividends for the
foreseeable future, investors may be forced to sell their stock to realize a return on their investment.

 

We do not anticipate that we will pay any dividends to holders
of our common stock for the foreseeable future. Any payment of cash dividends will be at the discretion of our board of directors
and will depend on, among other things, our results of operations, cash requirements, financial condition, contractual restrictions
including compliance with covenants under our debt agreements, and other factors that our board of directors may deem relevant.
Our ability to pay dividends might be restricted by the terms of any indebtedness that we incur in the future. In addition, certain
of our current outstanding debt agreements prohibit us from paying cash dividends on our common stock. Consequently, you should
not rely on dividends to receive a return on your investment.

 

Our common stock is still presently subject to the "Penny
Stock" rules of the SEC.

 

The Securities and Exchange Commission has adopted Rule 15g-9
which establishes the definition of a "penny stock," for the purposes relevant to us, as any equity security that has
a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain exceptions.
For any transaction involving a penny stock, unless exempt, the rules require:

 

		●	that a broker or dealer approve a person's account for transactions in penny stocks; and the broker or dealer receive from
the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.

 

In order to approve a person's account for transactions in penny
stocks, the broker or dealer must:

 

		●	obtain financial information and investment experience objectives of the person; and make a reasonable determination that the
transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters
to be capable of evaluating the risks of transactions in penny stocks.

 

The broker or dealer must also deliver, prior to any transaction
in a penny stock, a disclosure schedule prescribed by the Commission relating to the penny stock market, which, in highlight form:

 

		●	sets forth the basis on which the broker or dealer made the suitability determination; and

 

		●	that the broker or dealer received a signed, written agreement from the investor prior to the transaction.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]